Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
Identifieur interne : 000896 ( Pmc/Corpus ); précédent : 000895; suivant : 000897Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
Auteurs : Florent Morfoisse ; Edith Renaud ; Fransky Hantelys ; Anne-Catherine Prats ; Barbara Garmy-SusiniSource :
- Molecular & Cellular Oncology [ 2372-3556 ] ; 2015.
Abstract
Hypoxia is a major condition for the induction of angiogenesis during tumor development but its role in lymphangiogenesis remains unclear. Blood and lymphatic vasculatures are stimulated by growth factors from the vascular endothelial family: the VEGFs. In this review, we investigate the role of hypoxia in the molecular regulation of synthesis of lymphangiogenic growth factors VEGF-A, VEGF-C, and VEGF-D. Gene expression can be regulated at transcriptional and translational levels by hypoxia. Despite strong regulation of DNA transcription induced by hypoxia-inducible factors (HIFs), the majority of cellular stresses such as hypoxia lead to inhibition of cap-dependent translation of the mRNA, resulting in downregulation of protein synthesis. Here, we describe how translation initiation of VEGF mRNAs is induced by hypoxia through an internal ribosome entry site (IRES)-dependent mechanism. Considering the implication of the lymphatic vasculature in metastatic dissemination, it seems crucial to understand the hypoxia-induced molecular regulation of lymphangiogenic growth factors to obtain new insights for cancer therapy.
Url:
DOI: 10.1080/23723556.2015.1024821
PubMed: 27308508
PubMed Central: 4905355
Links to Exploration step
PMC:4905355Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis</title><author><name sortKey="Morfoisse, Florent" sort="Morfoisse, Florent" uniqKey="Morfoisse F" first="Florent" last="Morfoisse">Florent Morfoisse</name><affiliation><nlm:aff id="af0001"><institution>UMR 1048-I2MC, INSERM, UPS</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Renaud, Edith" sort="Renaud, Edith" uniqKey="Renaud E" first="Edith" last="Renaud">Edith Renaud</name><affiliation><nlm:aff id="af0002"><institution>TRADGENE, UPS (EA4554)</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Hantelys, Fransky" sort="Hantelys, Fransky" uniqKey="Hantelys F" first="Fransky" last="Hantelys">Fransky Hantelys</name><affiliation><nlm:aff id="af0002"><institution>TRADGENE, UPS (EA4554)</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Prats, Anne Catherine" sort="Prats, Anne Catherine" uniqKey="Prats A" first="Anne-Catherine" last="Prats">Anne-Catherine Prats</name><affiliation><nlm:aff id="af0002"><institution>TRADGENE, UPS (EA4554)</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Garmy Susini, Barbara" sort="Garmy Susini, Barbara" uniqKey="Garmy Susini B" first="Barbara" last="Garmy-Susini">Barbara Garmy-Susini</name><affiliation><nlm:aff id="af0001"><institution>UMR 1048-I2MC, INSERM, UPS</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27308508</idno><idno type="pmc">4905355</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905355</idno><idno type="RBID">PMC:4905355</idno><idno type="doi">10.1080/23723556.2015.1024821</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">000896</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000896</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis</title><author><name sortKey="Morfoisse, Florent" sort="Morfoisse, Florent" uniqKey="Morfoisse F" first="Florent" last="Morfoisse">Florent Morfoisse</name><affiliation><nlm:aff id="af0001"><institution>UMR 1048-I2MC, INSERM, UPS</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Renaud, Edith" sort="Renaud, Edith" uniqKey="Renaud E" first="Edith" last="Renaud">Edith Renaud</name><affiliation><nlm:aff id="af0002"><institution>TRADGENE, UPS (EA4554)</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Hantelys, Fransky" sort="Hantelys, Fransky" uniqKey="Hantelys F" first="Fransky" last="Hantelys">Fransky Hantelys</name><affiliation><nlm:aff id="af0002"><institution>TRADGENE, UPS (EA4554)</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Prats, Anne Catherine" sort="Prats, Anne Catherine" uniqKey="Prats A" first="Anne-Catherine" last="Prats">Anne-Catherine Prats</name><affiliation><nlm:aff id="af0002"><institution>TRADGENE, UPS (EA4554)</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author><author><name sortKey="Garmy Susini, Barbara" sort="Garmy Susini, Barbara" uniqKey="Garmy Susini B" first="Barbara" last="Garmy-Susini">Barbara Garmy-Susini</name><affiliation><nlm:aff id="af0001"><institution>UMR 1048-I2MC, INSERM, UPS</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></nlm:aff></affiliation></author></analytic><series><title level="j">Molecular & Cellular Oncology</title><idno type="eISSN">2372-3556</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Hypoxia is a major condition for the induction of angiogenesis during tumor development but its role in lymphangiogenesis remains unclear. Blood and lymphatic vasculatures are stimulated by growth factors from the vascular endothelial family: the VEGFs. In this review, we investigate the role of hypoxia in the molecular regulation of synthesis of lymphangiogenic growth factors VEGF-A, VEGF-C, and VEGF-D. Gene expression can be regulated at transcriptional and translational levels by hypoxia. Despite strong regulation of DNA transcription induced by hypoxia-inducible factors (HIFs), the majority of cellular stresses such as hypoxia lead to inhibition of cap-dependent translation of the mRNA, resulting in downregulation of protein synthesis. Here, we describe how translation initiation of VEGF mRNAs is induced by hypoxia through an internal ribosome entry site (IRES)-dependent mechanism. Considering the implication of the lymphatic vasculature in metastatic dissemination, it seems crucial to understand the hypoxia-induced molecular regulation of lymphangiogenic growth factors to obtain new insights for cancer therapy.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Jeltsch, M" uniqKey="Jeltsch M">M Jeltsch</name></author><author><name sortKey="Tammela, T" uniqKey="Tammela T">T Tammela</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author><author><name sortKey="Wilting, J" uniqKey="Wilting J">J Wilting</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Baluk, P" uniqKey="Baluk P">P Baluk</name></author><author><name sortKey="Tammela, T" uniqKey="Tammela T">T Tammela</name></author><author><name sortKey="Ator, E" uniqKey="Ator E">E Ator</name></author><author><name sortKey="Lyubynska, N" uniqKey="Lyubynska N">N Lyubynska</name></author><author><name sortKey="Achen, Mg" uniqKey="Achen M">MG Achen</name></author><author><name sortKey="Hicklin, Dj" uniqKey="Hicklin D">DJ Hicklin</name></author><author><name sortKey="Jeltsch, M" uniqKey="Jeltsch M">M Jeltsch</name></author><author><name sortKey="Petrova, Tv" uniqKey="Petrova T">TV Petrova</name></author><author><name sortKey="Pytowski, B" uniqKey="Pytowski B">B Pytowski</name></author><author><name sortKey="Stacker, Sa" uniqKey="Stacker S">SA Stacker</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author><author><name sortKey="Tammela, T" uniqKey="Tammela T">T Tammela</name></author><author><name sortKey="Petrova, Tv" uniqKey="Petrova T">TV Petrova</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Williams, Cs" uniqKey="Williams C">CS Williams</name></author><author><name sortKey="Leek, Rd" uniqKey="Leek R">RD Leek</name></author><author><name sortKey="Robson, Am" uniqKey="Robson A">AM Robson</name></author><author><name sortKey="Banerji, S" uniqKey="Banerji S">S Banerji</name></author><author><name sortKey="Prevo, R" uniqKey="Prevo R">R Prevo</name></author><author><name sortKey="Harris, Al" uniqKey="Harris A">AL Harris</name></author><author><name sortKey="Jackson, Dg" uniqKey="Jackson D">DG Jackson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mumprecht, V" uniqKey="Mumprecht V">V Mumprecht</name></author><author><name sortKey="Detmar, M" uniqKey="Detmar M">M Detmar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Renyi Vamos, F" uniqKey="Renyi Vamos F">F Renyi-Vamos</name></author><author><name sortKey="Tovari, J" uniqKey="Tovari J">J Tovari</name></author><author><name sortKey="Fillinger, J" uniqKey="Fillinger J">J Fillinger</name></author><author><name sortKey="Timar, J" uniqKey="Timar J">J Timar</name></author><author><name sortKey="Paku, S" uniqKey="Paku S">S Paku</name></author><author><name sortKey="Kenessey, I" uniqKey="Kenessey I">I Kenessey</name></author><author><name sortKey="Ostoros, G" uniqKey="Ostoros G">G Ostoros</name></author><author><name sortKey="Agocs, L" uniqKey="Agocs L">L Agocs</name></author><author><name sortKey="Soltesz, I" uniqKey="Soltesz I">I Soltesz</name></author><author><name sortKey="Dome, B" uniqKey="Dome B">B Dome</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zeng, Y" uniqKey="Zeng Y">Y Zeng</name></author><author><name sortKey="Opeskin, K" uniqKey="Opeskin K">K Opeskin</name></author><author><name sortKey="Horvath, Lg" uniqKey="Horvath L">LG Horvath</name></author><author><name sortKey="Sutherland, Rl" uniqKey="Sutherland R">RL Sutherland</name></author><author><name sortKey="Williams, Ed" uniqKey="Williams E">ED Williams</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stacker, Sa" uniqKey="Stacker S">SA Stacker</name></author><author><name sortKey="Williams, Ra" uniqKey="Williams R">RA Williams</name></author><author><name sortKey="Achen, Mg" uniqKey="Achen M">MG Achen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Baluk, P" uniqKey="Baluk P">P Baluk</name></author><author><name sortKey="Fuxe, J" uniqKey="Fuxe J">J Fuxe</name></author><author><name sortKey="Hashizume, H" uniqKey="Hashizume H">H Hashizume</name></author><author><name sortKey="Romano, T" uniqKey="Romano T">T Romano</name></author><author><name sortKey="Lashnits, E" uniqKey="Lashnits E">E Lashnits</name></author><author><name sortKey="Butz, S" uniqKey="Butz S">S Butz</name></author><author><name sortKey="Vestweber, D" uniqKey="Vestweber D">D Vestweber</name></author><author><name sortKey="Corada, M" uniqKey="Corada M">M Corada</name></author><author><name sortKey="Molendini, C" uniqKey="Molendini C">C Molendini</name></author><author><name sortKey="Dejana, E" uniqKey="Dejana E">E Dejana</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Leak, Lv" uniqKey="Leak L">LV Leak</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wigle, Jt" uniqKey="Wigle J">JT Wigle</name></author><author><name sortKey="Oliver, G" uniqKey="Oliver G">G Oliver</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Prevo, R" uniqKey="Prevo R">R Prevo</name></author><author><name sortKey="Banerji, S" uniqKey="Banerji S">S Banerji</name></author><author><name sortKey="Ferguson, Dj" uniqKey="Ferguson D">DJ Ferguson</name></author><author><name sortKey="Clasper, S" uniqKey="Clasper S">S Clasper</name></author><author><name sortKey="Jackson, Dg" uniqKey="Jackson D">DG Jackson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Banerji, S" uniqKey="Banerji S">S Banerji</name></author><author><name sortKey="Ni, J" uniqKey="Ni J">J Ni</name></author><author><name sortKey="Wang, Sx" uniqKey="Wang S">SX Wang</name></author><author><name sortKey="Clasper, S" uniqKey="Clasper S">S Clasper</name></author><author><name sortKey="Su, J" uniqKey="Su J">J Su</name></author><author><name sortKey="Tammi, R" uniqKey="Tammi R">R Tammi</name></author><author><name sortKey="Jones, M" uniqKey="Jones M">M Jones</name></author><author><name sortKey="Jackson, Dg" uniqKey="Jackson D">DG Jackson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Breiteneder Geleff, S" uniqKey="Breiteneder Geleff S">S Breiteneder-Geleff</name></author><author><name sortKey="Soleiman, A" uniqKey="Soleiman A">A Soleiman</name></author><author><name sortKey="Horvat, R" uniqKey="Horvat R">R Horvat</name></author><author><name sortKey="Amann, G" uniqKey="Amann G">G Amann</name></author><author><name sortKey="Kowalski, H" uniqKey="Kowalski H">H Kowalski</name></author><author><name sortKey="Kerjaschki, D" uniqKey="Kerjaschki D">D Kerjaschki</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karkkainen, Mj" uniqKey="Karkkainen M">MJ Karkkainen</name></author><author><name sortKey="Ferrell, Re" uniqKey="Ferrell R">RE Ferrell</name></author><author><name sortKey="Lawrence, Ec" uniqKey="Lawrence E">EC Lawrence</name></author><author><name sortKey="Lawrence, Ec" uniqKey="Lawrence E">EC Lawrence</name></author><author><name sortKey="Kimak, Ma" uniqKey="Kimak M">MA Kimak</name></author><author><name sortKey="Levinson, Kl" uniqKey="Levinson K">KL Levinson</name></author><author><name sortKey="Mctigue, Ma" uniqKey="Mctigue M">MA McTigue</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author><author><name sortKey="Finegold, Dn" uniqKey="Finegold D">DN Finegold</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kilic, N" uniqKey="Kilic N">N Kilic</name></author><author><name sortKey="Oliveira Ferrer, L" uniqKey="Oliveira Ferrer L">L Oliveira-Ferrer</name></author><author><name sortKey="Neshat Vahid, S" uniqKey="Neshat Vahid S">S Neshat-Vahid</name></author><author><name sortKey="Irmak, S" uniqKey="Irmak S">S Irmak</name></author><author><name sortKey="Obst Pernberg, K" uniqKey="Obst Pernberg K">K Obst-Pernberg</name></author><author><name sortKey="Wurmbach, Jh" uniqKey="Wurmbach J">JH Wurmbach</name></author><author><name sortKey="Loges, S" uniqKey="Loges S">S Loges</name></author><author><name sortKey="Kilic, E" uniqKey="Kilic E">E Kilic</name></author><author><name sortKey="Weil, J" uniqKey="Weil J">J Weil</name></author><author><name sortKey="Lauke, H" uniqKey="Lauke H">H Lauke</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Breslin, Jw" uniqKey="Breslin J">JW Breslin</name></author><author><name sortKey="Gaudreault, N" uniqKey="Gaudreault N">N Gaudreault</name></author><author><name sortKey="Watson, Kd" uniqKey="Watson K">KD Watson</name></author><author><name sortKey="Reynoso, R" uniqKey="Reynoso R">R Reynoso</name></author><author><name sortKey="Yuan, Sy" uniqKey="Yuan S">SY Yuan</name></author><author><name sortKey="Wu, Mh" uniqKey="Wu M">MH Wu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bridenbaugh, E" uniqKey="Bridenbaugh E">E Bridenbaugh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Makinen, T" uniqKey="Makinen T">T Makinen</name></author><author><name sortKey="Veikkola, T" uniqKey="Veikkola T">T Veikkola</name></author><author><name sortKey="Mustjoki, S" uniqKey="Mustjoki S">S Mustjoki</name></author><author><name sortKey="Karpanen, T" uniqKey="Karpanen T">T Karpanen</name></author><author><name sortKey="Catimel, B" uniqKey="Catimel B">B Catimel</name></author><author><name sortKey="Nice, Ec" uniqKey="Nice E">EC Nice</name></author><author><name sortKey="Wise, L" uniqKey="Wise L">L Wise</name></author><author><name sortKey="Mercer, A" uniqKey="Mercer A">A Mercer</name></author><author><name sortKey="Kowalski, H" uniqKey="Kowalski H">H Kowalski</name></author><author><name sortKey="Kerjaschki, D" uniqKey="Kerjaschki D">D Kerjaschki</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tammela, T" uniqKey="Tammela T">T Tammela</name></author><author><name sortKey="Zarkada, G" uniqKey="Zarkada G">G Zarkada</name></author><author><name sortKey="Wallgard, E" uniqKey="Wallgard E">E Wallgard</name></author><author><name sortKey="Murtom Ki, A" uniqKey="Murtom Ki A">A Murtomäki</name></author><author><name sortKey="Suchting, S" uniqKey="Suchting S">S Suchting</name></author><author><name sortKey="Wirzenius, M" uniqKey="Wirzenius M">M Wirzenius</name></author><author><name sortKey="Waltari, M" uniqKey="Waltari M">M Waltari</name></author><author><name sortKey="Hellstrom, M" uniqKey="Hellstrom M">M Hellström</name></author><author><name sortKey="Schomber, T" uniqKey="Schomber T">T Schomber</name></author><author><name sortKey="Peltonen, R" uniqKey="Peltonen R">R Peltonen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Petrova, Tv" uniqKey="Petrova T">TV Petrova</name></author><author><name sortKey="Bono, P" uniqKey="Bono P">P Bono</name></author><author><name sortKey="Holnthoner, W" uniqKey="Holnthoner W">W Holnthoner</name></author><author><name sortKey="Chesnes, J" uniqKey="Chesnes J">J Chesnes</name></author><author><name sortKey="Pytowski, B" uniqKey="Pytowski B">B Pytowski</name></author><author><name sortKey="Sihto, H" uniqKey="Sihto H">H Sihto</name></author><author><name sortKey="Laakkonen, P" uniqKey="Laakkonen P">P Laakkonen</name></author><author><name sortKey="Heikkil, P" uniqKey="Heikkil P">P Heikkilä</name></author><author><name sortKey="Joensuu, H" uniqKey="Joensuu H">H Joensuu</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ardies, Cm" uniqKey="Ardies C">CM Ardies</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Van Der Auwera, I" uniqKey="Van Der Auwera I">I Van der Auwera</name></author><author><name sortKey="Van Laere, Sj" uniqKey="Van Laere S">SJ Van Laere</name></author><author><name sortKey="Van Den Eynden, Gg" uniqKey="Van Den Eynden G">GG Van den Eynden</name></author><author><name sortKey="Benoy, I" uniqKey="Benoy I">I Benoy</name></author><author><name sortKey="Van Dam, P" uniqKey="Van Dam P">P van Dam</name></author><author><name sortKey="Colpaert, Cg" uniqKey="Colpaert C">CG Colpaert</name></author><author><name sortKey="Fox, Sb" uniqKey="Fox S">SB Fox</name></author><author><name sortKey="Turley, H" uniqKey="Turley H">H Turley</name></author><author><name sortKey="Harris, Al" uniqKey="Harris A">AL Harris</name></author><author><name sortKey="Van Marck, Ea" uniqKey="Van Marck E">EA Van Marck</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jaiswal, M" uniqKey="Jaiswal M">M Jaiswal</name></author><author><name sortKey="Larusso, Nf" uniqKey="Larusso N">NF LaRusso</name></author><author><name sortKey="Gores, Gj" uniqKey="Gores G">GJ Gores</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Brower, V" uniqKey="Brower V">V Brower</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Biarc, J" uniqKey="Biarc J">J Biarc</name></author><author><name sortKey="Nguyen, Is" uniqKey="Nguyen I">IS Nguyen</name></author><author><name sortKey="Pini, A" uniqKey="Pini A">A Pini</name></author><author><name sortKey="Gosse, F" uniqKey="Gosse F">F Gossé</name></author><author><name sortKey="Richert, S" uniqKey="Richert S">S Richert</name></author><author><name sortKey="Thierse, D" uniqKey="Thierse D">D Thiersé</name></author><author><name sortKey="Van Dorsselaer, A" uniqKey="Van Dorsselaer A">A Van Dorsselaer</name></author><author><name sortKey="Leize Wagner, E" uniqKey="Leize Wagner E">E Leize-Wagner</name></author><author><name sortKey="Raul, F" uniqKey="Raul F">F Raul</name></author><author><name sortKey="Klein, Jp" uniqKey="Klein J">JP Klein</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Altinoz, Ma" uniqKey="Altinoz M">MA Altinoz</name></author><author><name sortKey="Korkmaz, R" uniqKey="Korkmaz R">R Korkmaz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, W" uniqKey="Wang W">W Wang</name></author><author><name sortKey="Bergh, A" uniqKey="Bergh A">A Bergh</name></author><author><name sortKey="Damber, Je" uniqKey="Damber J">JE Damber</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hussein, Mr" uniqKey="Hussein M">MR Hussein</name></author><author><name sortKey="Ahmed, Ra" uniqKey="Ahmed R">RA Ahmed</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bartsch, H" uniqKey="Bartsch H">H Bartsch</name></author><author><name sortKey="Nair, J" uniqKey="Nair J">J Nair</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Angelo, Ls" uniqKey="Angelo L">LS Angelo</name></author><author><name sortKey="Kurzrock, R" uniqKey="Kurzrock R">R Kurzrock</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jain, Rk" uniqKey="Jain R">RK Jain</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Padera, Tp" uniqKey="Padera T">TP Padera</name></author><author><name sortKey="Kadambi, A" uniqKey="Kadambi A">A Kadambi</name></author><author><name sortKey="Di Tomaso, E" uniqKey="Di Tomaso E">E di Tomaso</name></author><author><name sortKey="Carreira, Cm" uniqKey="Carreira C">CM Carreira</name></author><author><name sortKey="Brown, Eb" uniqKey="Brown E">EB Brown</name></author><author><name sortKey="Boucher, Y" uniqKey="Boucher Y">Y Boucher</name></author><author><name sortKey="Choi, Nc" uniqKey="Choi N">NC Choi</name></author><author><name sortKey="Mathisen, D" uniqKey="Mathisen D">D Mathisen</name></author><author><name sortKey="Wain, J" uniqKey="Wain J">J Wain</name></author><author><name sortKey="Mark, Ej" uniqKey="Mark E">EJ Mark</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dadras, Ss" uniqKey="Dadras S">SS Dadras</name></author><author><name sortKey="Lange Asschenfeldt, B" uniqKey="Lange Asschenfeldt B">B Lange-Asschenfeldt</name></author><author><name sortKey="Velasco, P" uniqKey="Velasco P">P Velasco</name></author><author><name sortKey="Nguyen, L" uniqKey="Nguyen L">L Nguyen</name></author><author><name sortKey="Vora, A" uniqKey="Vora A">A Vora</name></author><author><name sortKey="Muzikansky, A" uniqKey="Muzikansky A">A Muzikansky</name></author><author><name sortKey="Jahnke, K" uniqKey="Jahnke K">K Jahnke</name></author><author><name sortKey="Hauschild, A" uniqKey="Hauschild A">A Hauschild</name></author><author><name sortKey="Hirakawa, S" uniqKey="Hirakawa S">S Hirakawa</name></author><author><name sortKey="Mihm, Mc" uniqKey="Mihm M">MC Mihm</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Maula, Sm" uniqKey="Maula S">SM Maula</name></author><author><name sortKey="Luukkaa, M" uniqKey="Luukkaa M">M Luukkaa</name></author><author><name sortKey="Grenman, R" uniqKey="Grenman R">R Grenman</name></author><author><name sortKey="Jackson, D" uniqKey="Jackson D">D Jackson</name></author><author><name sortKey="Jalkanen, S" uniqKey="Jalkanen S">S Jalkanen</name></author><author><name sortKey="Ristamaki, R" uniqKey="Ristamaki R">R Ristamaki</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Choi, Ww" uniqKey="Choi W">WW Choi</name></author><author><name sortKey="Lewis, Mm" uniqKey="Lewis M">MM Lewis</name></author><author><name sortKey="Lawson, D" uniqKey="Lawson D">D Lawson</name></author><author><name sortKey="Yin Goen, Q" uniqKey="Yin Goen Q">Q Yin-Goen</name></author><author><name sortKey="Birdsong, Gg" uniqKey="Birdsong G">GG Birdsong</name></author><author><name sortKey="Cotsonis, Ga" uniqKey="Cotsonis G">GA Cotsonis</name></author><author><name sortKey="Cohen, C" uniqKey="Cohen C">C Cohen</name></author><author><name sortKey="Young, An" uniqKey="Young A">AN Young</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bergers, G" uniqKey="Bergers G">G Bergers</name></author><author><name sortKey="Benjamin, Le" uniqKey="Benjamin L">LE Benjamin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Skobe, M" uniqKey="Skobe M">M Skobe</name></author><author><name sortKey="Hawighorst, T" uniqKey="Hawighorst T">T Hawighorst</name></author><author><name sortKey="Jackson, Dg" uniqKey="Jackson D">DG Jackson</name></author><author><name sortKey="Prevo, R" uniqKey="Prevo R">R Prevo</name></author><author><name sortKey="Janes, L" uniqKey="Janes L">L Janes</name></author><author><name sortKey="Velasco, P" uniqKey="Velasco P">P Velasco</name></author><author><name sortKey="Riccardi, L" uniqKey="Riccardi L">L Riccardi</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author><author><name sortKey="Claffey, K" uniqKey="Claffey K">K Claffey</name></author><author><name sortKey="Detmar, M" uniqKey="Detmar M">M Detmar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stacker, Sa" uniqKey="Stacker S">SA Stacker</name></author><author><name sortKey="Caesar, C" uniqKey="Caesar C">C Caesar</name></author><author><name sortKey="Baldwin, Me" uniqKey="Baldwin M">ME Baldwin</name></author><author><name sortKey="Thornton, Ge" uniqKey="Thornton G">GE Thornton</name></author><author><name sortKey="Williams, Ra" uniqKey="Williams R">RA Williams</name></author><author><name sortKey="Prevo, R" uniqKey="Prevo R">R Prevo</name></author><author><name sortKey="Jackson, Dg" uniqKey="Jackson D">DG Jackson</name></author><author><name sortKey="Nishikawa, S" uniqKey="Nishikawa S">S Nishikawa</name></author><author><name sortKey="Kubo, H" uniqKey="Kubo H">H Kubo</name></author><author><name sortKey="Achen, Mg" uniqKey="Achen M">MG Achen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Petrova, Tv" uniqKey="Petrova T">TV Petrova</name></author><author><name sortKey="Makinen, T" uniqKey="Makinen T">T Makinen</name></author><author><name sortKey="Makela, Tp" uniqKey="Makela T">TP Makela</name></author><author><name sortKey="Saarela, J" uniqKey="Saarela J">J Saarela</name></author><author><name sortKey="Virtanen, I" uniqKey="Virtanen I">I Virtanen</name></author><author><name sortKey="Ferrell, Re" uniqKey="Ferrell R">RE Ferrell</name></author><author><name sortKey="Finegold, Dn" uniqKey="Finegold D">DN Finegold</name></author><author><name sortKey="Kerjaschki, D" uniqKey="Kerjaschki D">D Kerjaschki</name></author><author><name sortKey="Yl Herttuala, S" uniqKey="Yl Herttuala S">S Ylä-Herttuala</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tal, O" uniqKey="Tal O">O Tal</name></author><author><name sortKey="Lim, Hy" uniqKey="Lim H">HY Lim</name></author><author><name sortKey="Gurevich, I" uniqKey="Gurevich I">I Gurevich</name></author><author><name sortKey="Milo, I" uniqKey="Milo I">I Milo</name></author><author><name sortKey="Shipony, Z" uniqKey="Shipony Z">Z Shipony</name></author><author><name sortKey="Ng, Lg" uniqKey="Ng L">LG Ng</name></author><author><name sortKey="Angeli, V" uniqKey="Angeli V">V Angeli</name></author><author><name sortKey="Shakhar, G" uniqKey="Shakhar G">G Shakhar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Issa, A" uniqKey="Issa A">A Issa</name></author><author><name sortKey="Le, Tx" uniqKey="Le T">TX Le</name></author><author><name sortKey="Shoushtari, An" uniqKey="Shoushtari A">AN Shoushtari</name></author><author><name sortKey="Shields, Jd" uniqKey="Shields J">JD Shields</name></author><author><name sortKey="Swartz, Ma" uniqKey="Swartz M">MA Swartz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ivanovic, Z" uniqKey="Ivanovic Z">Z Ivanovic</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Guzy, Rd" uniqKey="Guzy R">RD Guzy</name></author><author><name sortKey="Sharma, B" uniqKey="Sharma B">B Sharma</name></author><author><name sortKey="Bell, E" uniqKey="Bell E">E Bell</name></author><author><name sortKey="Chandel, Ns" uniqKey="Chandel N">NS Chandel</name></author><author><name sortKey="Schumacker, Pt" uniqKey="Schumacker P">PT Schumacker</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Morfoisse, F" uniqKey="Morfoisse F">F Morfoisse</name></author><author><name sortKey="Kuchnio, A" uniqKey="Kuchnio A">A Kuchnio</name></author><author><name sortKey="Frainay, C" uniqKey="Frainay C">C Frainay</name></author><author><name sortKey="Gomez Brouchet, A" uniqKey="Gomez Brouchet A">A Gomez-Brouchet</name></author><author><name sortKey="Delisle, Mb" uniqKey="Delisle M">MB Delisle</name></author><author><name sortKey="Marzi, S" uniqKey="Marzi S">S Marzi</name></author><author><name sortKey="Helfer, Ac" uniqKey="Helfer A">AC Helfer</name></author><author><name sortKey="Hantelys, F" uniqKey="Hantelys F">F Hantelys</name></author><author><name sortKey="Pujol, F" uniqKey="Pujol F">F Pujol</name></author><author><name sortKey="Guillermet Guibert, J" uniqKey="Guillermet Guibert J">J Guillermet-Guibert</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ivanovic, Z" uniqKey="Ivanovic Z">Z Ivanovic</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gerber, Hp" uniqKey="Gerber H">HP Gerber</name></author><author><name sortKey="Condorelli, F" uniqKey="Condorelli F">F Condorelli</name></author><author><name sortKey="Park, J" uniqKey="Park J">J Park</name></author><author><name sortKey="Ferrara, N" uniqKey="Ferrara N">N Ferrara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Iyer, Nv" uniqKey="Iyer N">NV Iyer</name></author><author><name sortKey="Kotch, Le" uniqKey="Kotch L">LE Kotch</name></author><author><name sortKey="Agani, F" uniqKey="Agani F">F Agani</name></author><author><name sortKey="Leung, Sw" uniqKey="Leung S">SW Leung</name></author><author><name sortKey="Laughner, E" uniqKey="Laughner E">E Laughner</name></author><author><name sortKey="Wenger, Rh" uniqKey="Wenger R">RH Wenger</name></author><author><name sortKey="Gassmann, M" uniqKey="Gassmann M">M Gassmann</name></author><author><name sortKey="Gearhart, Jd" uniqKey="Gearhart J">JD Gearhart</name></author><author><name sortKey="Lawler, Am" uniqKey="Lawler A">AM Lawler</name></author><author><name sortKey="Yu, Ay" uniqKey="Yu A">AY Yu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ryan, He" uniqKey="Ryan H">HE Ryan</name></author><author><name sortKey="Lo, J" uniqKey="Lo J">J Lo</name></author><author><name sortKey="Johnson, Rs" uniqKey="Johnson R">RS Johnson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Huang, Le" uniqKey="Huang L">LE Huang</name></author><author><name sortKey="Gu, J" uniqKey="Gu J">J Gu</name></author><author><name sortKey="Schau, M" uniqKey="Schau M">M Schau</name></author><author><name sortKey="Bunn, Hf" uniqKey="Bunn H">HF Bunn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bruick, Rk" uniqKey="Bruick R">RK Bruick</name></author><author><name sortKey="Mcknight, Sl" uniqKey="Mcknight S">SL McKnight</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mazzone, M" uniqKey="Mazzone M">M Mazzone</name></author><author><name sortKey="Dettori, D" uniqKey="Dettori D">D Dettori</name></author><author><name sortKey="Leite De Oliveira, R" uniqKey="Leite De Oliveira R">R Leite de Oliveira</name></author><author><name sortKey="Loges, S" uniqKey="Loges S">S Loges</name></author><author><name sortKey="Schmidt, T" uniqKey="Schmidt T">T Schmidt</name></author><author><name sortKey="Jonckx, B" uniqKey="Jonckx B">B Jonckx</name></author><author><name sortKey="Tian, Ym" uniqKey="Tian Y">YM Tian</name></author><author><name sortKey="Lanahan, Aa" uniqKey="Lanahan A">AA Lanahan</name></author><author><name sortKey="Pollard, P" uniqKey="Pollard P">P Pollard</name></author><author><name sortKey="Ruiz De Almodovar, C" uniqKey="Ruiz De Almodovar C">C Ruiz de Almodovar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jaakkola, P" uniqKey="Jaakkola P">P Jaakkola</name></author><author><name sortKey="Mole, Dr" uniqKey="Mole D">DR Mole</name></author><author><name sortKey="Tian, Ym" uniqKey="Tian Y">YM Tian</name></author><author><name sortKey="Wilson, Mi" uniqKey="Wilson M">MI Wilson</name></author><author><name sortKey="Gielbert, J" uniqKey="Gielbert J">J Gielbert</name></author><author><name sortKey="Gaskell, Sj" uniqKey="Gaskell S">SJ Gaskell</name></author><author><name sortKey="Von Kriegsheim, A" uniqKey="Von Kriegsheim A">A von Kriegsheim</name></author><author><name sortKey="Hebestreit, Hf" uniqKey="Hebestreit H">HF Hebestreit</name></author><author><name sortKey="Mukherji, M" uniqKey="Mukherji M">M Mukherji</name></author><author><name sortKey="Schofield, Cj" uniqKey="Schofield C">CJ Schofield</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ivan, M" uniqKey="Ivan M">M Ivan</name></author><author><name sortKey="Kondo, K" uniqKey="Kondo K">K Kondo</name></author><author><name sortKey="Yang, H" uniqKey="Yang H">H Yang</name></author><author><name sortKey="Kim, W" uniqKey="Kim W">W Kim</name></author><author><name sortKey="Valiando, J" uniqKey="Valiando J">J Valiando</name></author><author><name sortKey="Ohh, M" uniqKey="Ohh M">M Ohh</name></author><author><name sortKey="Salic, A" uniqKey="Salic A">A Salic</name></author><author><name sortKey="Asara, Jm" uniqKey="Asara J">JM Asara</name></author><author><name sortKey="Lane, Ws" uniqKey="Lane W">WS Lane</name></author><author><name sortKey="Kaelin, Wg" uniqKey="Kaelin W">WG Kaelin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ferrara, N" uniqKey="Ferrara N">N Ferrara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pages, G" uniqKey="Pages G">G Pages</name></author><author><name sortKey="Pouyssegur, J" uniqKey="Pouyssegur J">J Pouyssegur</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Forsythe, Ja" uniqKey="Forsythe J">JA Forsythe</name></author><author><name sortKey="Jiang, Bh" uniqKey="Jiang B">BH Jiang</name></author><author><name sortKey="Iyer, Nv" uniqKey="Iyer N">NV Iyer</name></author><author><name sortKey="Agani, F" uniqKey="Agani F">F Agani</name></author><author><name sortKey="Leung, Sw" uniqKey="Leung S">SW Leung</name></author><author><name sortKey="Koos, Rd" uniqKey="Koos R">RD Koos</name></author><author><name sortKey="Semenza, Gl" uniqKey="Semenza G">GL Semenza</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Blancher, C" uniqKey="Blancher C">C Blancher</name></author><author><name sortKey="Moore, Jw" uniqKey="Moore J">JW Moore</name></author><author><name sortKey="Talks, Kl" uniqKey="Talks K">KL Talks</name></author><author><name sortKey="Houlbrook, S" uniqKey="Houlbrook S">S Houlbrook</name></author><author><name sortKey="Harris, Al" uniqKey="Harris A">AL Harris</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gruber, Ar" uniqKey="Gruber A">AR Gruber</name></author><author><name sortKey="Fallmann, J" uniqKey="Fallmann J">J Fallmann</name></author><author><name sortKey="Kratochvill, F" uniqKey="Kratochvill F">F Kratochvill</name></author><author><name sortKey="Kovarik, P" uniqKey="Kovarik P">P Kovarik</name></author><author><name sortKey="Hofacker, Il" uniqKey="Hofacker I">IL Hofacker</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Levy, Ap" uniqKey="Levy A">AP Levy</name></author><author><name sortKey="Levy, Ns" uniqKey="Levy N">NS Levy</name></author><author><name sortKey="Goldberg, Ma" uniqKey="Goldberg M">MA Goldberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Griseri, P" uniqKey="Griseri P">P Griseri</name></author><author><name sortKey="Pages, G" uniqKey="Pages G">G Pages</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Onesto, C" uniqKey="Onesto C">C Onesto</name></author><author><name sortKey="Berra, E" uniqKey="Berra E">E Berra</name></author><author><name sortKey="Grepin, R" uniqKey="Grepin R">R Grepin</name></author><author><name sortKey="Pages, G" uniqKey="Pages G">G Pages</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chang, Sh" uniqKey="Chang S">SH Chang</name></author><author><name sortKey="Hla, T" uniqKey="Hla T">T Hla</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Holcik, M" uniqKey="Holcik M">M Holcik</name></author><author><name sortKey="Sonenberg, N" uniqKey="Sonenberg N">N Sonenberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Baird, Sd" uniqKey="Baird S">SD Baird</name></author><author><name sortKey="Turcotte, M" uniqKey="Turcotte M">M Turcotte</name></author><author><name sortKey="Korneluk, Rg" uniqKey="Korneluk R">RG Korneluk</name></author><author><name sortKey="Holcik, M" uniqKey="Holcik M">M Holcik</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Silvera, D" uniqKey="Silvera D">D Silvera</name></author><author><name sortKey="Schneider, Rj" uniqKey="Schneider R">RJ Schneider</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Somers, J" uniqKey="Somers J">J Somers</name></author><author><name sortKey="Poyry, T" uniqKey="Poyry T">T Poyry</name></author><author><name sortKey="Willis, Ae" uniqKey="Willis A">AE Willis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vagner, S" uniqKey="Vagner S">S Vagner</name></author><author><name sortKey="Galy, B" uniqKey="Galy B">B Galy</name></author><author><name sortKey="Pyronnet, S" uniqKey="Pyronnet S">S Pyronnet</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bushell, M" uniqKey="Bushell M">M Bushell</name></author><author><name sortKey="Stoneley, M" uniqKey="Stoneley M">M Stoneley</name></author><author><name sortKey="Sarnow, P" uniqKey="Sarnow P">P Sarnow</name></author><author><name sortKey="Willis, Ae" uniqKey="Willis A">AE Willis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Thakor, N" uniqKey="Thakor N">N Thakor</name></author><author><name sortKey="Holcik, M" uniqKey="Holcik M">M Holcik</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vagner, S" uniqKey="Vagner S">S Vagner</name></author><author><name sortKey="Gensac, Mc" uniqKey="Gensac M">MC Gensac</name></author><author><name sortKey="Maret, A" uniqKey="Maret A">A Maret</name></author><author><name sortKey="Bayard, F" uniqKey="Bayard F">F Bayard</name></author><author><name sortKey="Amalric, F" uniqKey="Amalric F">F Amalric</name></author><author><name sortKey="Prats, H" uniqKey="Prats H">H Prats</name></author><author><name sortKey="Prats, Ac" uniqKey="Prats A">AC Prats</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Huez, I" uniqKey="Huez I">I Huez</name></author><author><name sortKey="Creancier, L" uniqKey="Creancier L">L Creancier</name></author><author><name sortKey="Audigier, S" uniqKey="Audigier S">S Audigier</name></author><author><name sortKey="Gensac, Mc" uniqKey="Gensac M">MC Gensac</name></author><author><name sortKey="Prats, Ac" uniqKey="Prats A">AC Prats</name></author><author><name sortKey="Prats, H" uniqKey="Prats H">H Prats</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bornes, S" uniqKey="Bornes S">S Bornes</name></author><author><name sortKey="Prado Lourenco, L" uniqKey="Prado Lourenco L">L Prado-Lourenco</name></author><author><name sortKey="Bastide, A" uniqKey="Bastide A">A Bastide</name></author><author><name sortKey="Zanibellato, C" uniqKey="Zanibellato C">C Zanibellato</name></author><author><name sortKey="Iacovoni, Js" uniqKey="Iacovoni J">JS Iacovoni</name></author><author><name sortKey="Lacazette, E" uniqKey="Lacazette E">E Lacazette</name></author><author><name sortKey="Prats, Ac" uniqKey="Prats A">AC Prats</name></author><author><name sortKey="Touriol, C" uniqKey="Touriol C">C Touriol</name></author><author><name sortKey="Prats, H" uniqKey="Prats H">H Prats</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Arcondeguy, T" uniqKey="Arcondeguy T">T Arcondeguy</name></author><author><name sortKey="Lacazette, E" uniqKey="Lacazette E">E Lacazette</name></author><author><name sortKey="Millevoi, S" uniqKey="Millevoi S">S Millevoi</name></author><author><name sortKey="Prats, H" uniqKey="Prats H">H Prats</name></author><author><name sortKey="Touriol, C" uniqKey="Touriol C">C Touriol</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Keck, Pj" uniqKey="Keck P">PJ Keck</name></author><author><name sortKey="Hauser, Sd" uniqKey="Hauser S">SD Hauser</name></author><author><name sortKey="Krivi, G" uniqKey="Krivi G">G Krivi</name></author><author><name sortKey="Sanzo, K" uniqKey="Sanzo K">K Sanzo</name></author><author><name sortKey="Warren, T" uniqKey="Warren T">T Warren</name></author><author><name sortKey="Feder, J" uniqKey="Feder J">J Feder</name></author><author><name sortKey="Connolly, Dt" uniqKey="Connolly D">DT Connolly</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Leung, Dw" uniqKey="Leung D">DW Leung</name></author><author><name sortKey="Cachianes, G" uniqKey="Cachianes G">G Cachianes</name></author><author><name sortKey="Kuang, Wj" uniqKey="Kuang W">WJ Kuang</name></author><author><name sortKey="Goeddel, Dv" uniqKey="Goeddel D">DV Goeddel</name></author><author><name sortKey="Ferrara, N" uniqKey="Ferrara N">N Ferrara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tischer, E" uniqKey="Tischer E">E Tischer</name></author><author><name sortKey="Mitchell, R" uniqKey="Mitchell R">R Mitchell</name></author><author><name sortKey="Hartman, T" uniqKey="Hartman T">T Hartman</name></author><author><name sortKey="Silva, M" uniqKey="Silva M">M Silva</name></author><author><name sortKey="Gospodarowicz, D" uniqKey="Gospodarowicz D">D Gospodarowicz</name></author><author><name sortKey="Fiddes, Jc" uniqKey="Fiddes J">JC Fiddes</name></author><author><name sortKey="Abraham, Ja" uniqKey="Abraham J">JA Abraham</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Houck, Ka" uniqKey="Houck K">KA Houck</name></author><author><name sortKey="Leung, Dw" uniqKey="Leung D">DW Leung</name></author><author><name sortKey="Rowland, Am" uniqKey="Rowland A">AM Rowland</name></author><author><name sortKey="Winer, J" uniqKey="Winer J">J Winer</name></author><author><name sortKey="Ferrara, N" uniqKey="Ferrara N">N Ferrara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Carmeliet, P" uniqKey="Carmeliet P">P Carmeliet</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dellinger, Mt" uniqKey="Dellinger M">MT Dellinger</name></author><author><name sortKey="Brekken, Ra" uniqKey="Brekken R">RA Brekken</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wuest, Tr" uniqKey="Wuest T">TR Wuest</name></author><author><name sortKey="Carr, Dj" uniqKey="Carr D">DJ Carr</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bastide, A" uniqKey="Bastide A">A Bastide</name></author><author><name sortKey="Karaa, Z" uniqKey="Karaa Z">Z Karaa</name></author><author><name sortKey="Bornes, S" uniqKey="Bornes S">S Bornes</name></author><author><name sortKey="Hieblot, C" uniqKey="Hieblot C">C Hieblot</name></author><author><name sortKey="Lacazette, E" uniqKey="Lacazette E">E Lacazette</name></author><author><name sortKey="Prats, H" uniqKey="Prats H">H Prats</name></author><author><name sortKey="Touriol, C" uniqKey="Touriol C">C Touriol</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karaa, Zs" uniqKey="Karaa Z">ZS Karaa</name></author><author><name sortKey="Iacovoni, Js" uniqKey="Iacovoni J">JS Iacovoni</name></author><author><name sortKey="Bastide, A" uniqKey="Bastide A">A Bastide</name></author><author><name sortKey="Lacazette, E" uniqKey="Lacazette E">E Lacazette</name></author><author><name sortKey="Touriol, C" uniqKey="Touriol C">C Touriol</name></author><author><name sortKey="Prats, H" uniqKey="Prats H">H Prats</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Casanova, Cm" uniqKey="Casanova C">CM Casanova</name></author><author><name sortKey="Sehr, P" uniqKey="Sehr P">P Sehr</name></author><author><name sortKey="Putzker, K" uniqKey="Putzker K">K Putzker</name></author><author><name sortKey="Hentze, Mw" uniqKey="Hentze M">MW Hentze</name></author><author><name sortKey="Neumann, B" uniqKey="Neumann B">B Neumann</name></author><author><name sortKey="Duncan, Ke" uniqKey="Duncan K">KE Duncan</name></author><author><name sortKey="Thoma, C" uniqKey="Thoma C">C Thoma</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ray, Ps" uniqKey="Ray P">PS Ray</name></author><author><name sortKey="Jia, J" uniqKey="Jia J">J Jia</name></author><author><name sortKey="Yao, P" uniqKey="Yao P">P Yao</name></author><author><name sortKey="Majumder, M" uniqKey="Majumder M">M Majumder</name></author><author><name sortKey="Hatzoglou, M" uniqKey="Hatzoglou M">M Hatzoglou</name></author><author><name sortKey="Fox, Pl" uniqKey="Fox P">PL Fox</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Essafi Benkhadir, K" uniqKey="Essafi Benkhadir K">K Essafi-Benkhadir</name></author><author><name sortKey="Onesto, C" uniqKey="Onesto C">C Onesto</name></author><author><name sortKey="Stebe, E" uniqKey="Stebe E">E Stebe</name></author><author><name sortKey="Moroni, C" uniqKey="Moroni C">C Moroni</name></author><author><name sortKey="Pages, G" uniqKey="Pages G">G Pages</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhou, S" uniqKey="Zhou S">S Zhou</name></author><author><name sortKey="Gu, L" uniqKey="Gu L">L Gu</name></author><author><name sortKey="He, J" uniqKey="He J">J He</name></author><author><name sortKey="Zhang, H" uniqKey="Zhang H">H Zhang</name></author><author><name sortKey="Zhou, M" uniqKey="Zhou M">M Zhou</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vumbaca, F" uniqKey="Vumbaca F">F Vumbaca</name></author><author><name sortKey="Phoenix, Kn" uniqKey="Phoenix K">KN Phoenix</name></author><author><name sortKey="Rodriguez Pinto, D" uniqKey="Rodriguez Pinto D">D Rodriguez-Pinto</name></author><author><name sortKey="Han, Dk" uniqKey="Han D">DK Han</name></author><author><name sortKey="Claffey, Kp" uniqKey="Claffey K">KP Claffey</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Joukov, V" uniqKey="Joukov V">V Joukov</name></author><author><name sortKey="Pajusola, K" uniqKey="Pajusola K">K Pajusola</name></author><author><name sortKey="Kaipainen, A" uniqKey="Kaipainen A">A Kaipainen</name></author><author><name sortKey="Chilov, D" uniqKey="Chilov D">D Chilov</name></author><author><name sortKey="Lahtinen, I" uniqKey="Lahtinen I">I Lahtinen</name></author><author><name sortKey="Kukk, E" uniqKey="Kukk E">E Kukk</name></author><author><name sortKey="Saksela, O" uniqKey="Saksela O">O Saksela</name></author><author><name sortKey="Kalkkinen, N" uniqKey="Kalkkinen N">N Kalkkinen</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karpanen, T" uniqKey="Karpanen T">T Karpanen</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tammela, T" uniqKey="Tammela T">T Tammela</name></author><author><name sortKey="Saaristo, A" uniqKey="Saaristo A">A Saaristo</name></author><author><name sortKey="Lohela, M" uniqKey="Lohela M">M Lohela</name></author><author><name sortKey="Morisada, T" uniqKey="Morisada T">T Morisada</name></author><author><name sortKey="Tornberg, J" uniqKey="Tornberg J">J Tornberg</name></author><author><name sortKey="Norrmen, C" uniqKey="Norrmen C">C Norrmén</name></author><author><name sortKey="Oike, Y" uniqKey="Oike Y">Y Oike</name></author><author><name sortKey="Pajusola, K" uniqKey="Pajusola K">K Pajusola</name></author><author><name sortKey="Thurston, G" uniqKey="Thurston G">G Thurston</name></author><author><name sortKey="Suda, T" uniqKey="Suda T">T Suda</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karkkainen, Mj" uniqKey="Karkkainen M">MJ Karkkainen</name></author><author><name sortKey="Haiko, P" uniqKey="Haiko P">P Haiko</name></author><author><name sortKey="Sainio, K" uniqKey="Sainio K">K Sainio</name></author><author><name sortKey="Partanen, J" uniqKey="Partanen J">J Partanen</name></author><author><name sortKey="Taipale, J" uniqKey="Taipale J">J Taipale</name></author><author><name sortKey="Petrova, Tv" uniqKey="Petrova T">TV Petrova</name></author><author><name sortKey="Jeltsch, M" uniqKey="Jeltsch M">M Jeltsch</name></author><author><name sortKey="Jackson, Dg" uniqKey="Jackson D">DG Jackson</name></author><author><name sortKey="Talikka, M" uniqKey="Talikka M">M Talikka</name></author><author><name sortKey="Rauvala, H" uniqKey="Rauvala H">H Rauvala</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liang, X" uniqKey="Liang X">X Liang</name></author><author><name sortKey="Yang, D" uniqKey="Yang D">D Yang</name></author><author><name sortKey="Hu, J" uniqKey="Hu J">J Hu</name></author><author><name sortKey="Hao, X" uniqKey="Hao X">X Hao</name></author><author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name></author><author><name sortKey="Mao, Z" uniqKey="Mao Z">Z Mao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schoppmann, Sf" uniqKey="Schoppmann S">SF Schoppmann</name></author><author><name sortKey="Fenzl, A" uniqKey="Fenzl A">A Fenzl</name></author><author><name sortKey="Nagy, K" uniqKey="Nagy K">K Nagy</name></author><author><name sortKey="Unger, S" uniqKey="Unger S">S Unger</name></author><author><name sortKey="Bayer, G" uniqKey="Bayer G">G Bayer</name></author><author><name sortKey="Geleff, S" uniqKey="Geleff S">S Geleff</name></author><author><name sortKey="Gnant, M" uniqKey="Gnant M">M Gnant</name></author><author><name sortKey="Horvat, R" uniqKey="Horvat R">R Horvat</name></author><author><name sortKey="Jakesz, R" uniqKey="Jakesz R">R Jakesz</name></author><author><name sortKey="Birner, P" uniqKey="Birner P">P Birner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tao, J" uniqKey="Tao J">J Tao</name></author><author><name sortKey="Li, T" uniqKey="Li T">T Li</name></author><author><name sortKey="Li, K" uniqKey="Li K">K Li</name></author><author><name sortKey="Xiong, J" uniqKey="Xiong J">J Xiong</name></author><author><name sortKey="Yang, Z" uniqKey="Yang Z">Z Yang</name></author><author><name sortKey="Wu, H" uniqKey="Wu H">H Wu</name></author><author><name sortKey="Wang, C" uniqKey="Wang C">C Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chilov, D" uniqKey="Chilov D">D Chilov</name></author><author><name sortKey="Kukk, E" uniqKey="Kukk E">E Kukk</name></author><author><name sortKey="Taira, S" uniqKey="Taira S">S Taira</name></author><author><name sortKey="Jeltsch, M" uniqKey="Jeltsch M">M Jeltsch</name></author><author><name sortKey="Kaukonen, J" uniqKey="Kaukonen J">J Kaukonen</name></author><author><name sortKey="Palotie, A" uniqKey="Palotie A">A Palotie</name></author><author><name sortKey="Joukov, V" uniqKey="Joukov V">V Joukov</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stacker, Sa" uniqKey="Stacker S">SA Stacker</name></author><author><name sortKey="Achen, Mg" uniqKey="Achen M">MG Achen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karnezis, T" uniqKey="Karnezis T">T Karnezis</name></author><author><name sortKey="Shayan, R" uniqKey="Shayan R">R Shayan</name></author><author><name sortKey="Caesar, C" uniqKey="Caesar C">C Caesar</name></author><author><name sortKey="Roufail, S" uniqKey="Roufail S">S Roufail</name></author><author><name sortKey="Harris, Nc" uniqKey="Harris N">NC Harris</name></author><author><name sortKey="Ardipradja, K" uniqKey="Ardipradja K">K Ardipradja</name></author><author><name sortKey="Zhang, Yf" uniqKey="Zhang Y">YF Zhang</name></author><author><name sortKey="Williams, Sp" uniqKey="Williams S">SP Williams</name></author><author><name sortKey="Farnsworth, Rh" uniqKey="Farnsworth R">RH Farnsworth</name></author><author><name sortKey="Chai, Mg" uniqKey="Chai M">MG Chai</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karnezis, T" uniqKey="Karnezis T">T Karnezis</name></author><author><name sortKey="Shayan, R" uniqKey="Shayan R">R Shayan</name></author><author><name sortKey="Fox, S" uniqKey="Fox S">S Fox</name></author><author><name sortKey="Achen, Mg" uniqKey="Achen M">MG Achen</name></author><author><name sortKey="Stacker, Sa" uniqKey="Stacker S">SA Stacker</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stacker, Sa" uniqKey="Stacker S">SA Stacker</name></author><author><name sortKey="Williams, Sp" uniqKey="Williams S">SP Williams</name></author><author><name sortKey="Karnezis, T" uniqKey="Karnezis T">T Karnezis</name></author><author><name sortKey="Shayan, R" uniqKey="Shayan R">R Shayan</name></author><author><name sortKey="Fox, Sb" uniqKey="Fox S">SB Fox</name></author><author><name sortKey="Achen, Mg" uniqKey="Achen M">MG Achen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Okada, K" uniqKey="Okada K">K Okada</name></author><author><name sortKey="Osaki, M" uniqKey="Osaki M">M Osaki</name></author><author><name sortKey="Araki, K" uniqKey="Araki K">K Araki</name></author><author><name sortKey="Ishiguro, K" uniqKey="Ishiguro K">K Ishiguro</name></author><author><name sortKey="Ito, H" uniqKey="Ito H">H Ito</name></author><author><name sortKey="Ohgi, S" uniqKey="Ohgi S">S Ohgi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tzao, C" uniqKey="Tzao C">C Tzao</name></author><author><name sortKey="Lee, Sc" uniqKey="Lee S">SC Lee</name></author><author><name sortKey="Tung, Hj" uniqKey="Tung H">HJ Tung</name></author><author><name sortKey="Hsu, Hs" uniqKey="Hsu H">HS Hsu</name></author><author><name sortKey="Hsu, Wh" uniqKey="Hsu W">WH Hsu</name></author><author><name sortKey="Sun, Gh" uniqKey="Sun G">GH Sun</name></author><author><name sortKey="Yu, Cp" uniqKey="Yu C">CP Yu</name></author><author><name sortKey="Jin, Js" uniqKey="Jin J">JS Jin</name></author><author><name sortKey="Cheng, Yl" uniqKey="Cheng Y">YL Cheng</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Cell Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Mol Cell Oncol</journal-id><journal-id journal-id-type="pmc">KMCO</journal-id><journal-title-group><journal-title>Molecular & Cellular Oncology</journal-title></journal-title-group><issn pub-type="epub">2372-3556</issn><publisher><publisher-name>Taylor & Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27308508</article-id><article-id pub-id-type="pmc">4905355</article-id><article-id pub-id-type="publisher-id">1024821</article-id><article-id pub-id-type="doi">10.1080/23723556.2015.1024821</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Morfoisse</surname><given-names>Florent</given-names></name><xref ref-type="aff" rid="af0001"><sup>1</sup></xref><xref ref-type="corresp" rid="an0001"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Renaud</surname><given-names>Edith</given-names></name><xref ref-type="aff" rid="af0002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hantelys</surname><given-names>Fransky</given-names></name><xref ref-type="aff" rid="af0002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Prats</surname><given-names>Anne-Catherine</given-names></name><xref ref-type="aff" rid="af0002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Garmy-Susini</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="af0001"><sup>1</sup></xref></contrib><aff id="af0001"><label>1</label><institution>UMR 1048-I2MC, INSERM, UPS</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></aff><aff id="af0002"><label>2</label><institution>TRADGENE, UPS (EA4554)</institution>,<addr-line>F-31432</addr-line>, Toulouse,<country>France</country></aff></contrib-group><author-notes><corresp id="an0001"><label>*</label>Correspondence to: Florent Morfoisse; Email: <email xlink:href="barbara.garmy-susini@inserm.fr">barbara.garmy-susini@inserm.fr</email></corresp></author-notes><pub-date pub-type="collection"><season>Oct-Dec</season><year>2015</year></pub-date><pub-date pub-type="epub"><day>27</day><month>5</month><year>2015</year></pub-date><volume>2</volume><issue>4</issue><elocation-id seq="40">e1024821</elocation-id><history><date date-type="received"><day>4</day><month>6</month><year>2014</year></date><date date-type="rev-recd"><day>30</day><month>6</month><year>2014</year></date><date date-type="accepted"><day>6</day><month>7</month><year>2014</year></date></history><permissions><pmc-comment> © Florent Morfoisse, Edith Renaud, Fransky Hantelys, Anne-Catherine Prats, and Barbara Garmy-Susini </pmc-comment>
<copyright-statement>© 2015 The Author(s). Published with license by Taylor & Francis Group, LLC</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="kmco-02-04-1024821.pdf"></self-uri><abstract><p>Hypoxia is a major condition for the induction of angiogenesis during tumor development but its role in lymphangiogenesis remains unclear. Blood and lymphatic vasculatures are stimulated by growth factors from the vascular endothelial family: the VEGFs. In this review, we investigate the role of hypoxia in the molecular regulation of synthesis of lymphangiogenic growth factors VEGF-A, VEGF-C, and VEGF-D. Gene expression can be regulated at transcriptional and translational levels by hypoxia. Despite strong regulation of DNA transcription induced by hypoxia-inducible factors (HIFs), the majority of cellular stresses such as hypoxia lead to inhibition of cap-dependent translation of the mRNA, resulting in downregulation of protein synthesis. Here, we describe how translation initiation of VEGF mRNAs is induced by hypoxia through an internal ribosome entry site (IRES)-dependent mechanism. Considering the implication of the lymphatic vasculature in metastatic dissemination, it seems crucial to understand the hypoxia-induced molecular regulation of lymphangiogenic growth factors to obtain new insights for cancer therapy.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>hypoxia</kwd><kwd>lymphangiogenesis</kwd><kwd>transcription</kwd><kwd>translation</kwd><kwd>VEGF</kwd></kwd-group><counts><fig-count count="2"></fig-count><table-count count="0"></table-count><ref-count count="102"></ref-count><page-count count="8"></page-count></counts></article-meta></front><body><sec><title>Abbreviations</title><def-list><def-item><term>ARE</term><def><p>(AU)-rich elements</p></def></def-item><def-item><term>CCL21</term><def><p>Chemokine (C-C motif) ligand 21</p></def></def-item><def-item><term>CCR7</term><def><p>C-C chemokine receptor type 7</p></def></def-item><def-item><term>DEAD</term><def><p>sequence D-E-A-D (asp-glu-ala-asp)</p></def></def-item><def-item><term>eIF</term><def><p>eukaryotic initiation factor</p></def></def-item><def-item><term>FGF</term><def><p>fibroblast growth factor</p></def></def-item><def-item><term>FLT</term><def><p>fms-related tyrosine kinase 4</p></def></def-item><def-item><term>HIF</term><def><p>Hypoxia-inducible factor</p></def></def-item><def-item><term>HRE</term><def><p>hypoxia response element</p></def></def-item><def-item><term>hnRNP</term><def><p>heterogeneous nuclear ribonucleoproteins</p></def></def-item><def-item><term>IRES</term><def><p>internal ribosome entry site</p></def></def-item><def-item><term>LEC</term><def><p>lymphatic endothelial cell MAPK, mitogen-activated protein kinases</p></def></def-item><def-item><term>ORF</term><def><p>open reading frame</p></def></def-item><def-item><term>PAIP2</term><def><p>poly(A) binding protein interacting protein 2</p></def></def-item><def-item><term>PDGF</term><def><p>platelet-derived growth factor</p></def></def-item><def-item><term>PGDH</term><def><p>prostaglandin dehydrogenase</p></def></def-item><def-item><term>PGE2</term><def><p>prostaglandin E2</p></def></def-item><def-item><term>SMC</term><def><p>smooth muscle cell</p></def></def-item><def-item><term>TTP</term><def><p>tristetrapolin</p></def></def-item><def-item><term>UTR</term><def><p>untranslated region</p></def></def-item><def-item><term>VEGF</term><def><p>vascular endothelial growth factor</p></def></def-item><def-item><term>VEGFR</term><def><p>vascular endothelial growth factor receptor</p></def></def-item></def-list></sec><sec id="s0001"><title>The Lymphatic Network</title><p>The lymphatic vasculature consists of a network of lymph vessels whose main function is to return interstitial protein-rich fluid back to the circulating blood. Fluid, macromolecules, and cells, such as leukocytes and activated antigen-presenting cells, enter the lymphatic system through the blind-ended lymphatic capillaries. From here, lymph is transported toward collecting lymphatic vessels and is returned to the blood circulation in the jugular area through the lymphatico-venous junctions.<sup><xref rid="cit0001" ref-type="bibr">1</xref></sup> On its way, lymph is filtered through the lymph nodes, where foreign particles taken up by antigen-presenting cells are used to initiate specific immune responses.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> In the small intestine, lacteal lymphatic vessels inside the intestinal villi absorb the dietary fat released by enterocytes in the form of lipid particles called chylomicrons. In addition to these physiologic tasks, the lymphatic system participates in pathologic conditions such as lymphedema, inflammatory diseases, and tumor metastasis. Many studies have demonstrated the existence of proliferative peri- and intratumoral lymphatic vessels.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> Additionally, tumoral lymphangiogenesis correlates with an increase in metastases<sup><xref rid="cit0004" ref-type="bibr">4,5</xref></sup> and detection of lymphangiogenic growth factors is associated with poor prognosis in many human tumors.<sup><xref rid="cit0006" ref-type="bibr">6-8</xref></sup></p><p>Similar to blood capillaries, lymphatic capillaries are thin-walled, relatively large vessels composed of a single layer of endothelial cells, but they are not covered by pericytes or smooth muscle cells (SMCs) and have an absent or poorly developed basement membrane.<sup><xref rid="cit0009" ref-type="bibr">9</xref></sup> In addition, they lack tight junctions and adherens junctions, which allow easy access for fluid, macromolecules, and cells into the vessel lumen.<sup><xref rid="cit0010" ref-type="bibr">10</xref></sup> Initial lymphatics combine to form larger vessels called precollectors and collectors, which in turn lead to 4 major groups of lymph nodes in the axillary and inguinal regions. Endothelial cells of lymphatic capillaries are oak-leaf shaped and are characterized by discontinuous VE-Cadherin–positive button-like junctions. Collecting lymphatic vessels downstream have continuous zipper-like junctions previously described in blood vessels,<sup><xref rid="cit0009" ref-type="bibr">9</xref></sup> a smooth muscle cell layer, basement membrane, and valves.</p></sec><sec id="s0002"><title>Lymphatic Markers</title><p>Lymphatic vessels were first described in the beginning of the seventeenth century; however, the first growth factors and molecular markers specific for these vessels were discovered only 10 to 15 years ago: Prox1, the main transcriptional factor implicated in lymphatic vasculature development,<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> lymphatic vascular endothelial-cell hyaluronan receptor-1 (LYVE-1),<sup><xref rid="cit0012" ref-type="bibr">12</xref></sup> a new homolog of the CD44 glycoprotein and a lymph-specific receptor for hyaluronan,<sup><xref rid="cit0013" ref-type="bibr">13</xref></sup> and podoplanin, a transmembrane glycoprotein molecule.<sup><xref rid="cit0014" ref-type="bibr">14</xref></sup> Although the blood and lymphatic vascular systems are structurally related and function in concert, these specific markers have allowed investigation of the unique features of lymph vessels. Vascular endothelial growth factor receptor (VEGFR)-3 (also known as FLT-4) has been described as an major marker of lymphatics<sup><xref rid="cit0015" ref-type="bibr">15,16</xref></sup> because in the adult its expression becomes restricted to the lymphatic endothelium.<sup><xref rid="cit0017" ref-type="bibr">17–19</xref></sup> However, recent findings have shown that VEGFR-3 is also upregulated on vascular endothelial cells in angiogenic sprouts and is present on vessels in tumors and wounds.<sup><xref rid="cit0020" ref-type="bibr">20,21</xref></sup></p></sec><sec id="s0003"><title>Lymphangiogenesis in Pathology</title><p>In adult organisms, lymphangiogenesis takes place only in certain pathologic conditions. Abnormal function of the lymphatics is implicated in certain diseases, such as lymphedema, inflammation, immune diseases, and tumor metastasis.</p><p>Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return and swelling of the extremities. When the lymphatic system has been damaged during surgery or radiation treatment, its capacity to absorb excess water and cells from the interstitial space is reduced. If the transport capacity is reduced such that it cannot handle this increase in lymphatic load, an insufficiency of the lymphatic system may occur. Lymphedema can be an unfortunate side effect of cancer treatment. It is a chronic condition that, if ignored, can lead to disfigurement, immobilization, and severe infections. Without treatment, the swelling may continue to increase.</p><p>Inflammation is thought to contribute to the development and progression of various cancers, including lung,<sup><xref rid="cit0022" ref-type="bibr">22</xref></sup> breast,<sup><xref rid="cit0023" ref-type="bibr">23</xref></sup> gastrointestinal,<sup><xref rid="cit0024" ref-type="bibr">24-26</xref></sup> ovarian,<sup><xref rid="cit0027" ref-type="bibr">27</xref></sup> prostate,<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> skin,<sup><xref rid="cit0029" ref-type="bibr">29</xref></sup> and liver cancers.<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup></p><p>Inflammatory breast cancer exhibits increased angiogenesis and lymphangiogenesis and has a higher metastatic potential than noninflammatory breast cancer.<sup><xref rid="cit0031" ref-type="bibr">31</xref></sup> Blocking lymphangiogenesis in chronic inflammatory diseases may become an important means of ameliorating the severity of some of these pathologies.</p><p>The extent of lymph node metastasis is a major determinant for the staging and the prognosis of most human malignancies. Although the clinical significance of lymph node involvement is well documented, molecular mechanisms that promote tumor spread into the lymphatic or blood vascular systems and its widespread dissemination are not well understood. Recent studies have provided a large body of evidence indicating that newly visualized lymphatics facilitate formation of metastases. High tumor interstitial fluid pressure is thought to promote tumor cell entry into lymphatic vessels that have lower fluid pressure.<sup><xref rid="cit0032" ref-type="bibr">32,33</xref></sup> Intratumoral lymphatic vessel growth often correlates with metastasis of human melanoma, breast, or head and neck cancers,<sup><xref rid="cit0034" ref-type="bibr">34-36</xref></sup> in which tumor cells can be observed within lymphatic vessels, thus demonstrating that lymphatic vessel growth is important for tumor spread (<xref ref-type="fig" rid="f0001"><bold>Fig. 1</bold></xref>).
<fig id="f0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Hypoxic tumor cells (blue) near pre-existing blood and lymphatic vessels secrete (lymph)angiogenic growth factors such as vascular endothelial growth factor (VEGF)-A, -C, and –D to promote angiogenesis and lymphangiogenesis. Blood vessels bring oxygen and nutriments to tumor cells, whereas the lymphatics drain debris and provide new routes for tumor metastasis. Lymphatic metastatic tumor cells maintain synthesis of lymphangiogenic growth factors in this low-oxygenated system to promote lymph node lymphangiogenesis and establish the “metastatic niche.”</p></caption><graphic specific-use="web-only" xlink:href="kmco-02-04-1024821-g001"></graphic></fig></p></sec><sec id="s0004"><title>Tumor Growth, Hypoxia, and Lymphangiogenesis</title><p>As solid tumors grow in size, the cells within the expanding mass frequently become hypoxic because of the increasing distance from the nearest blood vessels. Thus, without an adequate vascular supply, solid tumors can grow only to a critical size of 1–2 mm (or approximately 10<sup>6</sup> cells), primarily due to lack of oxygen and nutrients.<sup><xref rid="cit0037" ref-type="bibr">37</xref></sup> Therefore, a number of studies have been performed to characterize and then inhibit tumor angiogenesis. However, considering the hypoxia-induced regulation of lymphangiogenic factors it is crucial to regard tumor hypoxia and tumor lymphangiogenesis as 2 tightly interlocked phenomena. In contrast to blood vessels, the lymphatic vasculature does not promote tumor growth by providing key elements for cell survival (i.e., oxygen, nutrients) but allows metastatic dissemination of most solid tumors through the lymph nodes and finally to distant organs.<sup><xref rid="cit0038" ref-type="bibr">38,39</xref></sup> The lymphatic network is not merely an alternative route into the blood vessels for dissemination but in fact constitutes the main vascular system implicated in dissemination as lymphatic vessels have an optimal structure for tumor cell invasion. Indeed, the main difference between the blood and lymphatic networks is the structure and permeability of their capillaries: the lymphatic capillaries are thin-walled, relatively large vessels, composed of a single layer of endothelial cells. In contrast to blood vessels, lymphatic capillaries are not ensheathed by pericytes or smooth muscle cells, and have little or no basement membrane.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> As a result of this high permeability, tumor cells can spread more easily in lymphatics than in blood vessels. This invasion is also not only a passive process as tumors induce new growth of lymphatic vessels in draining lymph nodes and enlargement of the lymphatic endothelium before metastasis. This remodeling of lymph nodes potentially contributes to the migration, implantation, or survival of metastatic tumor cells by inducing a specific tumor microenvironment. Thus, a hypoxic tumor will not only ensure its survival through activation of angiogenesis, but will also become more aggressive. This dual regulation of the blood and lymphatic vasculature by hypoxia during tumor growth also influences therapeutic options. First, there is a real crosstalk between tumor, blood, and lymphatic endothelial cells. Blood vessel endothelial cells produce lymphangiogenic factors such as VEGF-C, fibroblast growth factor (FGF)2, and platelet-derived growth factors (PDGFs) to facilitate tumor-induced lymphangiogenesis.<sup><xref rid="cit0040" ref-type="bibr">40</xref></sup> Both endothelial cell types also produce matrix metalloproteinases that promote tumor spreading. Lymphatic endothelial cells (LECs) additionally express the CCL21 chemokine that is implicated physiologically in dendritic cell mobilization<sup><xref rid="cit0041" ref-type="bibr">41</xref></sup> and interacts with the CCR7 receptor expressed by many tumors and thus stimulates lymphatic dissemination.<sup><xref rid="cit0042" ref-type="bibr">42</xref></sup> Several treatments have been developed to specifically inhibit tumor angiogenesis (i.e., Avastin) and therefore suppress tumor oxygenation and so destroy tumor cells. However, the severe tumor hypoxia induced by these drugs induces overexpression of lymphangiogenic factors and increases lymphangiogenesis, thus increasing tumor dissemination. This collaboration between hypoxia and the 2 vascular systems to ensure tumor spreading can explain some of the failures of anti-angiogenic drugs in cancer treatment. Another striking difference between blood and lymphatic vasculature is that lymph vessels are often located in remote areas away from oxygen-carrying blood vessels and do not transport oxygen-carrying red blood cells. Therefore, a key feature of the lymphatic system is its hypoxic environment, and tumor cells have to adapt to this hostile environment in order to spread to the lymph nodes (<xref ref-type="fig" rid="f0001"><bold>Fig. 1</bold></xref>).</p><p>Normoxia is defined as a milieu where the O<sub>2</sub> concentration is sufficient to ensure the aerobic metabolism of cells, which is the basis of eukaryotic physiology.<sup><xref rid="cit0046" ref-type="bibr">46</xref></sup> Hypoxia, in contrast, is an environment where the aerobic metabolism of cells is inhibited due to lack of oxygen. The major cellular response to hypoxia is stabilization of hypoxia-inducible factor 1 (HIF1). HIF1 is a transcription factor that controls the expression of a battery of more than 40 target genes.<sup><xref rid="cit0047" ref-type="bibr">47-49</xref></sup> It is composed of an α subunit that is constitutively expressed and a β subunit that is subjected to rapid ubiquitination and proteasomal degradation under normoxic conditions.<sup><xref rid="cit0050" ref-type="bibr">50</xref></sup> The molecular basis for this regulation is the O<sub>2</sub>-dependent hydroxylation of proline residues 402 and 564 in HIF-1α by any 1 of 3 enzymes in mammals that have been designated prolyl hydroxylase-domain proteins, or HIF-1α prolyl hydroxylases.<sup><xref rid="cit0051" ref-type="bibr">51,52</xref></sup> Prolyl hydroxylation of HIF-1α is required for binding of the von Hippel–Lindau tumor suppressor protein (VHL), the recognition component of an E3 ubiquitin-protein ligase that targets HIF-1α for proteasomal degradation.<sup><xref rid="cit0053" ref-type="bibr">53,54</xref></sup> Hypoxia has been shown to regulate not only angiogenesis but also lymphangiogenesis by promoting the overexpression of both specific lymphangiogenic factors (i.e., VEGF-C) and growth factors shared by the vascular and the lymphatic vasculature (i.e., VEGF-A, FGF2). Here, we provide an overview of the links between lymphangiogenic factors and hypoxia and the consequences of these relationships in a well-known hypoxic pathology—the development and dissemination of solid tumors.</p></sec><sec id="s0005"><title>Hypoxia-induced Molecular Regulation of VEGFs</title><p>The VEGF family is composed of growth factors involved in vascular development, including the vascular endothelial growth factors VEGF-A, VEGF-B, VEGF-C, VEGF-D, and VEGF-E, and the placental growth factor.<sup><xref rid="cit0055" ref-type="bibr">55</xref></sup> All members of this family stimulate proliferation and migration of endothelial cells in vitro. They bind and activate specific receptors on the endothelial cell surface: VEGF recognizes VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1); placental growth factor and VEGF-B recognize VEGFR-1; VEGF-C and VEGF-D recognize VEGFR-2 and VEGFR-3 (Flt-4). Lymphangiogenesis is induced by VEGFs that promote both angiogenesis (VEGF-A) and lymphangiogenesis (VEGF-C and VEGF-D).</p><p>Hypoxia-induced gene expression was first described as a transcriptional mechanism mediated by hypoxia-responsive elements present in the promoter regions of different genes that are targets of the hypoxia-induced HIF transcription factors. In particular, a functional hypoxia response element has been identified within the human 5´ flanking region of the VEGF-A gene<sup><xref rid="cit0056" ref-type="bibr">56,57</xref></sup> that is the target of both HIF-1 and HIF-2<sup><xref rid="cit0058" ref-type="bibr">58</xref></sup> and allows transcriptional induction of VEGF-A by hypoxia in several physiologic (i.e., wound healing, inflammation) and pathologic (i.e., ischemia, tumor development) states.</p><p>In addition to its transcriptional effects, hypoxia also regulates gene expression post-transcriptionally, at the levels of mRNA stability and translation. An important class of mRNAs is stabilized by hypoxia: the so-called of AU-rich mRNAs, which possess AU-rich elements (AREs) in their 3´ untranslated regions (3´UTRs).<sup><xref rid="cit0059" ref-type="bibr">59,60</xref></sup> AREs are found in most mRNAs coding for cytokines, growth factors, and proto-oncogenes (7–8% of the transcribed genome), indicating that the stabilization of such mRNAs in hypoxic conditions has drastic consequences on cell pathophysiology. In particular, angiogenic cytokines, including VEGF-A, are regulated by this mechanism.<sup><xref rid="cit0061" ref-type="bibr">61</xref></sup> mRNA stabilization is controlled by the binding of the protein HuR to the ARE, in cooperation with polyA-binding protein interacting protein 2 (PAIP2).<sup><xref rid="cit0062" ref-type="bibr">62</xref></sup> One proposed mechanism is that HuR acts through competition with destabilizing proteins such as AUF1 or tristetraprolin (TTP) for binding to the ARE.<sup><xref rid="cit0061" ref-type="bibr">61</xref></sup> Another emerging concept is that HuR counteracts the binding of microRNAs to the mRNA 3´UTR.<sup><xref rid="cit0063" ref-type="bibr">63</xref></sup> In the case of <italic>Vegfa</italic> mRNA, the HuR binding site overlaps with the binding site of miR-200b, thus HuR antagonizes the suppressive effect of this microRNA.<sup><xref rid="cit0063" ref-type="bibr">63</xref></sup></p><p>Hypoxia also strongly regulates gene expression at the translational level. First, it silences global cell translation by inhibiting mRNA cap-dependent translation through inactivation of mTOR kinase, resulting in hypophosphorylation of the 4E-BP protein, which thus sequesters the cap-binding factor eIF4E.<sup><xref rid="cit0064" ref-type="bibr">64,65</xref></sup> In addition, hypoxia induces phosphorylation of the initiation factor eIF2a by activation of PERK kinase, which also generates translational blockade.<sup><xref rid="cit0066" ref-type="bibr">66</xref></sup> Two main alternative mechanisms are able to overcome this global translation inhibition induced by hypoxia: upstream open reading frames (uORFs) and internal ribosome entry sites (IRESs). uORFs are a key element of translational control in response to stress. These elements precede the initiation codon of the mRNA main coding region and are present in approximately 40–50% of mRNAs. They are mostly translational inhibitors when eIF2a is dephosphorylated and the complex of the initiator tRNA with eIF2 and GTP is available for translation initiation. In contrast, they allow the ribosome to scan and reach the initiation codon of the main coding sequence in conditions of stress, when eIF2a is phosphorylated.<sup><xref rid="cit0067" ref-type="bibr">67</xref></sup></p><p>IRESs are RNA structural elements present in the 5´ non-translated regions of a small number of mRNAs that allow recruitment of the ribosome to a site that is a considerable distance from the cap structure, most frequently in the presence of trans-acting factors.<sup><xref rid="cit0064" ref-type="bibr">64,68</xref></sup> The majority of identified IRESs are found in mRNAs of proteins that are associated with the control of cell growth and death, including growth factors, proto-oncogenes, and proteins required for apoptosis.<sup><xref rid="cit0065" ref-type="bibr">65,69</xref></sup> IRES-dependent translation is cap-independent and, for cellular mRNAs, independent of eIF2a phosphorylation; this allows translation to occur in stress conditions.<sup><xref rid="cit0064" ref-type="bibr">64,70</xref></sup> Notably, HIF1α mRNA itself possesses an IRES suggesting that these structures are crucial for translational regulation occurring under hypoxia. IRESs have also been identified in the mRNAs of 3 major lymphangiogenic growth factors, FGF2, VEGF-A, and VEGF-C.<sup><xref rid="cit0071" ref-type="bibr">71,72</xref></sup> Interestingly, these 3 IRESs are activated in hypoxic conditions, resulting in translational induction of these factors.<sup><xref rid="cit0045" ref-type="bibr">45,73</xref></sup> The regulation of VEGF-A and -C expression and their relationship with hypoxia is developed below.</p></sec><sec id="s0006"><title>VEGF-A</title><p>VEGF-A, which is also called vascular permeability factor, is a homodimeric glycoprotein with a molecular weight of approximately 45 kDa. At least 9 VEGF isoforms exist as a result of alternative patterns of splicing.<sup><xref rid="cit0074" ref-type="bibr">74</xref></sup> Three of these, the VEGF isoforms of 121, 165, and 189 amino acids, are preferentially expressed by VEGF-A–producing cells.<sup><xref rid="cit0075" ref-type="bibr">75-77</xref></sup> Each of the isoforms contributes to form a VEGF-A gradient essential for proper migration of endothelial cells (ECs) or LECs during (lymph)angiogenesis: the larger species, VEGF-165, VEGF-189 and VEGF-206, are basic and bind to isolated heparin and heparin proteoglycans distributed on cellular surfaces and extracellular matrices whereas the smaller species, VEGF-121, is acidic and freely diffusible (<xref ref-type="fig" rid="f0002"><bold>Fig. 2A</bold></xref>).<sup><xref rid="cit0078" ref-type="bibr">78</xref></sup> Although VEGF-A is primarily known as a growth factor that plays an essential role in physiologic and pathologic angiogenesis both during development and adulthood,<sup><xref rid="cit0079" ref-type="bibr">79</xref></sup> it has been shown that it also has pro-lymphangiogenic properties.<sup><xref rid="cit0080" ref-type="bibr">80,81</xref></sup> The pro-angiogenic activity of VEGF-A is mediated by interaction with a high-affinity VEGFR2 receptor, whereas the pro-lymphangiogenic activity is promoted by binding to the VEGFR2/R3 heterodimeric receptor.
<fig id="f0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Schematic representation of vascular endothelial growth factor (VEGF)-A, -C, and -D mRNAs. (<bold>A</bold>) VEGF-A mRNA is characterized by a long 5´UTR (1,038nt) containing 2 internal ribosome entry sites (IRES; A and B). The VEGF-A gene encodes multiple isoforms generated by mRNA splicing of 4 constitutive and 4 alternative exons. (<bold>B</bold>) VEGF-C mRNA possesses a GC-rich 5´UTR containing an IRES. The secondary structure of VEGF-C IRES has been quantified by shape analysis and shows 2 motifs (squares) with a similar reactivity pattern between human and mouse mRNA. (<bold>C</bold>) Similar to VEGF-C, VEGF-D is encoded by 7 exons.</p></caption><graphic xlink:href="kmco-02-04-1024821-g002"></graphic></fig></p><p>In addition to its transcriptional upregulation during hypoxia, VEGF-A is probably the most highly post-transcriptionally regulated factor.<sup><xref rid="cit0074" ref-type="bibr">74</xref></sup> VEGF-A mRNA contains 2 IRESs<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> and their structures have been predicted <italic>in silico</italic> (<xref ref-type="fig" rid="f0002"><bold>Fig. 2A</bold></xref>). Each of these IRESs is located upstream from alternative initiation codons CUG and AUG responsible for the synthesis of alternative isoforms of VEGF-A.<sup><xref rid="cit0074" ref-type="bibr">74</xref></sup> and both of them are activated by hypoxia.<sup><xref rid="cit0073" ref-type="bibr">73</xref></sup><italic>Vegfa</italic> IRESs are differently regulated by an upstream ORF, as well as by Mir16 bound to the 3´UTR.<sup><xref rid="cit0082" ref-type="bibr">82,83</xref></sup> Study of VEGF-A IRES trans-acting factors suggest tight regulation, as both positive regulators activated by hypoxia (MAPK3 kinase) and negative regulators inhibited during this stress (DEAD-box RNA helicase 6) have been identified.<sup><xref rid="cit0084" ref-type="bibr">84</xref></sup> Another mechanism implicated in translation regulation of VEGF-A is riboswitch, the ability of mRNAs to alter their folding structure and thus their rate of translation in response to environmental modification. During hypoxia, intracellular accumulation of hnRNP L promotes an active conformation and increases the rate of translation of VEGF-A mRNA.<sup><xref rid="cit0085" ref-type="bibr">85</xref></sup> VEGF-A expression is strongly regulated at the level of mRNA stability, a process mainly mediated by the AREs present in the <italic>Vegfa</italic> mRNA. Indeed, the <italic>Vegfa</italic> mRNA is destabilized by several proteins including AUF1 and tristetraprolin (TTP), which target the AREs.<sup><xref rid="cit0061" ref-type="bibr">61</xref></sup> Destabilization of <italic>Vegfa</italic> mRNA by TTP is responsible for the antiangiogenic effect of this protein.<sup><xref rid="cit0086" ref-type="bibr">86</xref></sup> In contrast, <italic>Vegfa</italic> mRNA is stabilized by hypoxia.<sup><xref rid="cit0060" ref-type="bibr">60</xref></sup> This process is mediated by binding of the RNA stabilizing protein HuR and its partner PAIP2 to the AREs, which prevents binding of the destabilizing proteins.<sup><xref rid="cit0060" ref-type="bibr">60,61</xref></sup> Interestingly, the MDM2 protein, which is translocated from the nucleus to the cytoplasm under hypoxic conditions, also participates in <italic>Vegfa</italic> mRNA stabilization and allows an increase in <italic>Vegfa</italic> mRNA.<sup><xref rid="cit0087" ref-type="bibr">87</xref></sup><italic>Vegfa</italic> mRNA stability is thus controlled by an interplay between stabilizing and destabilizing proteins that compete for the AREs. Moreover, it has been proposed that <italic>Vegfa</italic> mRNA export from the nucleus and loading onto ribosomes can be increased during hypoxia by extra-nuclear shuttling of mRNA-binding proteins such as hnRNP L and A1, which also regulate <italic>Vegfa</italic> mRNA stability.<sup><xref rid="cit0088" ref-type="bibr">88</xref></sup> Together, these mechanisms contribute to the transcriptional regulation induced by HIFs to allow a fast and massive overexpression of VEGF-A in response to hypoxia.</p></sec><sec id="s0007"><title>VEGF-C</title><p>The VEGF-C/VEGFR3 signaling pathway, identified in 1996,<sup><xref rid="cit0089" ref-type="bibr">89</xref></sup> is the main pathway implicated in lymphangiogenesis. VEGF-C is produced as a precursor protein, which is activated by intracellular proprotein convertases.<sup><xref rid="cit0089" ref-type="bibr">89,90</xref></sup> The secreted disulphide-linked VEGF-C subunits only bind VEGFR-3, but the factor is further proteolyzed in the extracellular environment by plasmin and other proteases to generate non–disulfide-linked homodimeric proteins with high affinity for both VEGFR-2 and VEGFR-3.<sup><xref rid="cit0003" ref-type="bibr">3,90</xref></sup> VEGF-C is crucial for the induction of proliferation and migration and the survival of endothelial cells.<sup><xref rid="cit0091" ref-type="bibr">91</xref></sup> VEGF-C is also an essential chemotactic and survival factor during embryonic lymphangiogenesis as homozygous deletion of VEGF-C leads to complete absence of the lymphatic vasculature in mouse embryos, whereas <italic>VEGF-C</italic><sup>+/−</sup> mice display severe lymphatic hypoplasia. In VEGF-C null mice, lymphatic endothelial cells initially differentiate in the cardinal veins but fail to migrate and to form primary lymph sacs.<sup><xref rid="cit0092" ref-type="bibr">92</xref></sup> Although several studies have shown positive correlations between HIF-1α and VEGF-C in various cancers<sup><xref rid="cit0093" ref-type="bibr">93-95</xref></sup> the molecular mechanisms of hypoxia-induced regulation of VEGF-C remained poorly understood for a long time. Direct transcriptional regulation of VEGF-C by HIF-1α is unlikely as the promoter of VEGF-C does not contain an HRE sequence.<sup><xref rid="cit0096" ref-type="bibr">96</xref></sup> Our recent work has demonstrated the existence of an IRES in the 5´UTR of both murine and human VEGF-C mRNA (<xref ref-type="fig" rid="f0002"><bold>Fig. 2B</bold></xref>). As for the IRES of FGF2 and VEGF-A, VEGF-C IRES activity has been analyzed <italic>in vivo</italic> and we have demonstrated that VEGF-C IRES activity is upregulated during tumor growth in 3 murine models of carcinoma.<sup><xref rid="cit0045" ref-type="bibr">45</xref></sup> Strikingly, we also observed that VEGF-C IRES activity increases under hypoxia <italic>in vitro</italic> but does not require the presence of HIF-1α in cells.</p></sec><sec id="s0008"><title>VEGF-D</title><p>VEGF-D, also called c-fos–induced growth factor, binds its receptor VEGFR-3 to promote lymphangiogenesis. The VEGF-D gene contains 7 exons (<xref ref-type="fig" rid="f0002"><bold>Fig. 2C</bold></xref>). Maturation of VEGF-D is similar to that of VEGF-C and occurs by protein cleavage in N- and C-terminal regions. VEGF-D has been poorly studied due to the lack of phenotype generated by its invalidation in mice. Recent reports have shown that overexpression of VEGF-D induces tumor lymphangiogenesis and promotes lymphatic metastasis in mouse tumor models.<sup><xref rid="cit0097" ref-type="bibr">97</xref></sup> However, few clinical studies have investigated the association between the expression of VEGF-D and lymphatic metastasis. VEGF-D overexpression correlates with an increase of lymphatic vessel growth and lymphatic metastasis.<sup><xref rid="cit0039" ref-type="bibr">39</xref></sup> Recent studies suggest that VEGF-D is necessary for the entry of tumor cells into the lymphatic system for metastasis.<sup><xref rid="cit0098" ref-type="bibr">98</xref></sup> VEGF-D promotes structural changes in tumor-draining lymphatic vessels and induces vasodilatation. VEGF-D also increases endothelial response to prostaglandin E2 (PGE2) by inhibiting the prostaglandin dehydrogenases (PGDHs).<sup><xref rid="cit0099" ref-type="bibr">99,100</xref></sup></p><p>The role of hypoxia in promoting VEGF-D expression has not been clearly established. Recent studies have demonstrated correlations between VEGF-D and HIF-1α expression in invasive breast ductal carcinoma<sup><xref rid="cit0101" ref-type="bibr">101</xref></sup> and in resected esophageal squamous cell carcinoma.<sup><xref rid="cit0102" ref-type="bibr">102</xref></sup></p><p>These findings revealed that expression of lymphangiogenic factors is tightly linked to hypoxia, which is able to activate their expression at both transcriptional and translational levels. It is now well known that, at least in solid tumors, hypoxia is a major component of the tumor microenvironment and induces critical changes in tumor cell metabolism, angiogenesis, and lymphangiogenesis.</p></sec><sec id="s0009"><title>Concluding remarks and perspectives</title><p>The lymphatic vasculature has for a long time been considered the poor relation of the blood vasculature. Compared to the vascular network that provides both oxygen and nutrients, and is thus obviously necessary for life, the lymphatic system appeared to be a lesser vascular network. In addition, until recently it remained challenging to differentiate lymph from blood vessels due to a lack of specific markers. Recently, the lymphatic system has emerged as a vasculature that plays a crucial role in development and adulthood, and is not only implicated specifically in chronic inflammatory and vascular pathologies (psoriasis, lymphedema) but is also able to interact with blood vessels in cancer. Indeed, recent studies have highlighted the hypoxia-induced regulation of lymphangiogenic factor VEGF-C, demonstrating that understanding the molecular regulation of lymphangiogenesis in a wide range of organs and pathologies would offer a better understanding of such diseases and lead to new therapeutic solutions.</p></sec></body><back><sec id="s0010" sec-type="other"><title>Disclosure of Potential Conflicts of Interest</title><p>No potential conflicts of interest were disclosed.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeltsch</surname><given-names>M</given-names></name>, <name><surname>Tammela</surname><given-names>T</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name>, <name><surname>Wilting</surname><given-names>J</given-names></name></person-group>. <article-title>Genesis and pathogenesis of lymphatic vessels</article-title>. <source>Cell Tissue Res</source><year>2003</year>; <volume>314</volume>(<issue>1</issue>):<fpage>69</fpage>-<lpage>84</lpage>; PMID:12942362; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/s00441-003-0777-2</pub-id><pub-id pub-id-type="pmid">12942362</pub-id></mixed-citation></ref><ref id="cit0002"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baluk</surname><given-names>P</given-names></name>, <name><surname>Tammela</surname><given-names>T</given-names></name>, <name><surname>Ator</surname><given-names>E</given-names></name>, <name><surname>Lyubynska</surname><given-names>N</given-names></name>, <name><surname>Achen</surname><given-names>MG</given-names></name>, <name><surname>Hicklin</surname><given-names>DJ</given-names></name>, <name><surname>Jeltsch</surname><given-names>M</given-names></name>, <name><surname>Petrova</surname><given-names>TV</given-names></name>, <name><surname>Pytowski</surname><given-names>B</given-names></name>, <name><surname>Stacker</surname><given-names>SA</given-names></name>, et al.</person-group><article-title>Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation</article-title>. <source>J Clin Invest</source><year>2005</year>; <volume>115</volume>(<issue>2</issue>):<fpage>247</fpage>-<lpage>57</lpage>; PMID:15668734; http://dx.doi.org/<pub-id pub-id-type="doi">10.1172/JCI200522037</pub-id><pub-id pub-id-type="pmid">15668734</pub-id></mixed-citation></ref><ref id="cit0003"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alitalo</surname><given-names>K</given-names></name>, <name><surname>Tammela</surname><given-names>T</given-names></name>, <name><surname>Petrova</surname><given-names>TV</given-names></name></person-group>. <article-title>Lymphangiogenesis in development and human disease</article-title>. <source>Nature</source><year>2005</year>; <volume>438</volume>(<issue>7070</issue>):<fpage>946</fpage>-<lpage>53</lpage>; PMID:16355212; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature04480</pub-id><pub-id pub-id-type="pmid">16355212</pub-id></mixed-citation></ref><ref id="cit0004"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>CS</given-names></name>, <name><surname>Leek</surname><given-names>RD</given-names></name>, <name><surname>Robson</surname><given-names>AM</given-names></name>, <name><surname>Banerji</surname><given-names>S</given-names></name>, <name><surname>Prevo</surname><given-names>R</given-names></name>, <name><surname>Harris</surname><given-names>AL</given-names></name>, <name><surname>Jackson</surname><given-names>DG</given-names></name></person-group>. <article-title>Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer</article-title>. <source>J Pathol</source><year>2003</year>; <volume>200</volume>(<issue>2</issue>):<fpage>195</fpage>-<lpage>206</lpage>; PMID:12754740; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/path.1343</pub-id><pub-id pub-id-type="pmid">12754740</pub-id></mixed-citation></ref><ref id="cit0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumprecht</surname><given-names>V</given-names></name>, <name><surname>Detmar</surname><given-names>M</given-names></name></person-group>. <article-title>Lymphangiogenesis and cancer metastasis</article-title>. <source>J Cell Mol Med</source><year>2009</year>; <volume>13</volume>(<issue>8A</issue>):<fpage>1405</fpage>-<lpage>16</lpage>; PMID:19583813; http://dx.doi.org/<pub-id pub-id-type="doi">10.1111/j.1582-4934.2009.00834.x</pub-id><pub-id pub-id-type="pmid">19583813</pub-id></mixed-citation></ref><ref id="cit0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renyi-Vamos</surname><given-names>F</given-names></name>, <name><surname>Tovari</surname><given-names>J</given-names></name>, <name><surname>Fillinger</surname><given-names>J</given-names></name>, <name><surname>Timar</surname><given-names>J</given-names></name>, <name><surname>Paku</surname><given-names>S</given-names></name>, <name><surname>Kenessey</surname><given-names>I</given-names></name>, <name><surname>Ostoros</surname><given-names>G</given-names></name>, <name><surname>Agocs</surname><given-names>L</given-names></name>, <name><surname>Soltesz</surname><given-names>I</given-names></name>, <name><surname>Dome</surname><given-names>B</given-names></name></person-group>. <article-title>Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer</article-title>. <source>Clin Cancer Res</source><year>2005</year>; <volume>11</volume>(<issue>20</issue>):<fpage>7344</fpage>-<lpage>53</lpage>; PMID:16243806; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-1077</pub-id><pub-id pub-id-type="pmid">16243806</pub-id></mixed-citation></ref><ref id="cit0007"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Y</given-names></name>, <name><surname>Opeskin</surname><given-names>K</given-names></name>, <name><surname>Horvath</surname><given-names>LG</given-names></name>, <name><surname>Sutherland</surname><given-names>RL</given-names></name>, <name><surname>Williams</surname><given-names>ED</given-names></name></person-group>. <article-title>Lymphatic vessel density and lymph node metastasis in prostate cancer</article-title>. <source>Prostate</source><year>2005</year>; <volume>65</volume>(<issue>3</issue>):<fpage>222</fpage>-<lpage>30</lpage>; PMID:15948136; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/pros.20288</pub-id><pub-id pub-id-type="pmid">15948136</pub-id></mixed-citation></ref><ref id="cit0008"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacker</surname><given-names>SA</given-names></name>, <name><surname>Williams</surname><given-names>RA</given-names></name>, <name><surname>Achen</surname><given-names>MG</given-names></name></person-group>. <article-title>Lymphangiogenic growth factors as markers of tumor metastasis</article-title>. <source>Apmis</source><year>2004</year>; <volume>112</volume>(<issue>7-8</issue>):<fpage>539</fpage>-<lpage>49</lpage>; PMID:15563315; http://dx.doi.org/<pub-id pub-id-type="doi">10.1111/j.1600-0463.2004.apm11207-0812.x</pub-id><pub-id pub-id-type="pmid">15563315</pub-id></mixed-citation></ref><ref id="cit0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baluk</surname><given-names>P</given-names></name>, <name><surname>Fuxe</surname><given-names>J</given-names></name>, <name><surname>Hashizume</surname><given-names>H</given-names></name>, <name><surname>Romano</surname><given-names>T</given-names></name>, <name><surname>Lashnits</surname><given-names>E</given-names></name>, <name><surname>Butz</surname><given-names>S</given-names></name>, <name><surname>Vestweber</surname><given-names>D</given-names></name>, <name><surname>Corada</surname><given-names>M</given-names></name>, <name><surname>Molendini</surname><given-names>C</given-names></name>, <name><surname>Dejana</surname><given-names>E</given-names></name>, et al.</person-group><article-title>Functionally specialized junctions between endothelial cells of lymphatic vessels</article-title>. <source>J Exp Med</source><year>2007</year>; <volume>204</volume>(<issue>10</issue>):<fpage>2349</fpage>-<lpage>62</lpage>; PMID:17846148; http://dx.doi.org/<pub-id pub-id-type="doi">10.1084/jem.20062596</pub-id><pub-id pub-id-type="pmid">17846148</pub-id></mixed-citation></ref><ref id="cit0010"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leak</surname><given-names>LV</given-names></name></person-group>. <article-title>The structure of lymphatic capillaries in lymph formation</article-title>. <source>Fed Proc</source><year>1976</year>; <volume>35</volume>(<issue>8</issue>):<fpage>1863</fpage>-<lpage>71</lpage>; PMID:1269772<pub-id pub-id-type="pmid">1269772</pub-id></mixed-citation></ref><ref id="cit0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wigle</surname><given-names>JT</given-names></name>, <name><surname>Oliver</surname><given-names>G</given-names></name></person-group>. <article-title>Prox1 function is required for the development of the murine lymphatic system</article-title>. <source>Cell</source><year>1999</year>; <volume>98</volume>(<issue>6</issue>):<fpage>769</fpage>-<lpage>78</lpage>; PMID:10499794; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81511-1</pub-id><pub-id pub-id-type="pmid">10499794</pub-id></mixed-citation></ref><ref id="cit0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prevo</surname><given-names>R</given-names></name>, <name><surname>Banerji</surname><given-names>S</given-names></name>, <name><surname>Ferguson</surname><given-names>DJ</given-names></name>, <name><surname>Clasper</surname><given-names>S</given-names></name>, <name><surname>Jackson</surname><given-names>DG</given-names></name></person-group>. <article-title>Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium</article-title>. <source>J Biol Chem</source><year>2001</year>; <volume>276</volume>(<issue>22</issue>):<fpage>19420</fpage>-<lpage>30</lpage>; PMID:11278811; http://dx.doi.org/<pub-id pub-id-type="doi">10.1074/jbc.M011004200</pub-id><pub-id pub-id-type="pmid">11278811</pub-id></mixed-citation></ref><ref id="cit0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerji</surname><given-names>S</given-names></name>, <name><surname>Ni</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>SX</given-names></name>, <name><surname>Clasper</surname><given-names>S</given-names></name>, <name><surname>Su</surname><given-names>J</given-names></name>, <name><surname>Tammi</surname><given-names>R</given-names></name>, <name><surname>Jones</surname><given-names>M</given-names></name>, <name><surname>Jackson</surname><given-names>DG</given-names></name></person-group>. <article-title>LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan</article-title>. <source>J Cell Biol</source><year>1999</year>; <volume>144</volume>(<issue>4</issue>):<fpage>789</fpage>-<lpage>801</lpage>; PMID:10037799; http://dx.doi.org/<pub-id pub-id-type="doi">10.1083/jcb.144.4.789</pub-id><pub-id pub-id-type="pmid">10037799</pub-id></mixed-citation></ref><ref id="cit0014"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breiteneder-Geleff</surname><given-names>S</given-names></name>, <name><surname>Soleiman</surname><given-names>A</given-names></name>, <name><surname>Horvat</surname><given-names>R</given-names></name>, <name><surname>Amann</surname><given-names>G</given-names></name>, <name><surname>Kowalski</surname><given-names>H</given-names></name>, <name><surname>Kerjaschki</surname><given-names>D</given-names></name></person-group>. <article-title>[Podoplanin-a specific marker for lymphatic endothelium expressed in angiosarcoma]</article-title>. <source>Verh Dtsch Ges Pathol</source><year>1999</year>; <volume>83</volume>:<fpage>270</fpage>-<lpage>5</lpage>; PMID:10714221<pub-id pub-id-type="pmid">10714221</pub-id></mixed-citation></ref><ref id="cit0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkkainen</surname><given-names>MJ</given-names></name>, <name><surname>Ferrell</surname><given-names>RE</given-names></name>, <name><surname>Lawrence</surname><given-names>EC</given-names></name>, <name><surname>Lawrence</surname><given-names>EC</given-names></name>, <name><surname>Kimak</surname><given-names>MA</given-names></name>, <name><surname>Levinson</surname><given-names>KL</given-names></name>, <name><surname>McTigue</surname><given-names>MA</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name>, <name><surname>Finegold</surname><given-names>DN</given-names></name></person-group>. <article-title>Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema</article-title>. <source>Nat Genet</source><year>2000</year>; <volume>25</volume>(<issue>2</issue>):<fpage>153</fpage>-<lpage>9</lpage>; PMID:10835628; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/75997</pub-id><pub-id pub-id-type="pmid">10835628</pub-id></mixed-citation></ref><ref id="cit0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilic</surname><given-names>N</given-names></name>, <name><surname>Oliveira-Ferrer</surname><given-names>L</given-names></name>, <name><surname>Neshat-Vahid</surname><given-names>S</given-names></name>, <name><surname>Irmak</surname><given-names>S</given-names></name>, <name><surname>Obst-Pernberg</surname><given-names>K</given-names></name>, <name><surname>Wurmbach</surname><given-names>JH</given-names></name>, <name><surname>Loges</surname><given-names>S</given-names></name>, <name><surname>Kilic</surname><given-names>E</given-names></name>, <name><surname>Weil</surname><given-names>J</given-names></name>, <name><surname>Lauke</surname><given-names>H</given-names></name>, et al.</person-group><article-title>Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1</article-title>. <source>Blood</source><year>2007</year>; <volume>110</volume>(<issue>13</issue>):<fpage>4223</fpage>-<lpage>33</lpage>; PMID:17761831; http://dx.doi.org/<pub-id pub-id-type="doi">10.1182/blood-2007-06-097592</pub-id><pub-id pub-id-type="pmid">17761831</pub-id></mixed-citation></ref><ref id="cit0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breslin</surname><given-names>JW</given-names></name>, <name><surname>Gaudreault</surname><given-names>N</given-names></name>, <name><surname>Watson</surname><given-names>KD</given-names></name>, <name><surname>Reynoso</surname><given-names>R</given-names></name>, <name><surname>Yuan</surname><given-names>SY</given-names></name>, <name><surname>Wu</surname><given-names>MH</given-names></name></person-group>. <article-title>Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism</article-title>. <source>Am J Physiol Heart Circ Physiol</source><year>2007</year>; <volume>293</volume>(<issue>1</issue>):<fpage>H709</fpage>-<lpage>18</lpage>; PMID:17400713; http://dx.doi.org/<pub-id pub-id-type="doi">10.1152/ajpheart.00102.2007</pub-id><pub-id pub-id-type="pmid">17400713</pub-id></mixed-citation></ref><ref id="cit0018"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridenbaugh</surname><given-names>E</given-names></name></person-group>. <article-title>Literature watch. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody</article-title>. <source>Lymphat Res Biol</source><year>2005</year>; <volume>3</volume>(<issue>2</issue>):<fpage>87</fpage>-<lpage>8</lpage>; PMID:16000057; http://dx.doi.org/<pub-id pub-id-type="doi">10.1089/lrb.2005.3.87</pub-id><pub-id pub-id-type="pmid">16000057</pub-id></mixed-citation></ref><ref id="cit0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makinen</surname><given-names>T</given-names></name>, <name><surname>Veikkola</surname><given-names>T</given-names></name>, <name><surname>Mustjoki</surname><given-names>S</given-names></name>, <name><surname>Karpanen</surname><given-names>T</given-names></name>, <name><surname>Catimel</surname><given-names>B</given-names></name>, <name><surname>Nice</surname><given-names>EC</given-names></name>, <name><surname>Wise</surname><given-names>L</given-names></name>, <name><surname>Mercer</surname><given-names>A</given-names></name>, <name><surname>Kowalski</surname><given-names>H</given-names></name>, <name><surname>Kerjaschki</surname><given-names>D</given-names></name>, et al.</person-group><article-title>Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3</article-title>. <source>Embo J</source><year>2001</year>; <volume>20</volume>(<issue>17</issue>):<fpage>4762</fpage>-<lpage>73</lpage>; PMID:11532940; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/emboj/20.17.4762</pub-id><pub-id pub-id-type="pmid">11532940</pub-id></mixed-citation></ref><ref id="cit0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammela</surname><given-names>T</given-names></name>, <name><surname>Zarkada</surname><given-names>G</given-names></name>, <name><surname>Wallgard</surname><given-names>E</given-names></name>, <name><surname>Murtomäki</surname><given-names>A</given-names></name>, <name><surname>Suchting</surname><given-names>S</given-names></name>, <name><surname>Wirzenius</surname><given-names>M</given-names></name>, <name><surname>Waltari</surname><given-names>M</given-names></name>, <name><surname>Hellström</surname><given-names>M</given-names></name>, <name><surname>Schomber</surname><given-names>T</given-names></name>, <name><surname>Peltonen</surname><given-names>R</given-names></name>, et al.</person-group><article-title>Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation</article-title>. <source>Nature</source><year>2008</year>; <volume>454</volume>(<issue>7204</issue>):<fpage>656</fpage>-<lpage>60</lpage>; PMID:18594512; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature07083</pub-id><pub-id pub-id-type="pmid">18594512</pub-id></mixed-citation></ref><ref id="cit0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrova</surname><given-names>TV</given-names></name>, <name><surname>Bono</surname><given-names>P</given-names></name>, <name><surname>Holnthoner</surname><given-names>W</given-names></name>, <name><surname>Chesnes</surname><given-names>J</given-names></name>, <name><surname>Pytowski</surname><given-names>B</given-names></name>, <name><surname>Sihto</surname><given-names>H</given-names></name>, <name><surname>Laakkonen</surname><given-names>P</given-names></name>, <name><surname>Heikkilä</surname><given-names>P</given-names></name>, <name><surname>Joensuu</surname><given-names>H</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name></person-group>. <article-title>VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors</article-title>. <source>Cancer Cell</source><year>2008</year>; <volume>13</volume>(<issue>6</issue>):<fpage>554</fpage>-<lpage>6</lpage>; PMID:18538738; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.ccr.2008.04.022</pub-id><pub-id pub-id-type="pmid">18538738</pub-id></mixed-citation></ref><ref id="cit0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardies</surname><given-names>CM</given-names></name></person-group>. <article-title>Inflammation as cause for scar cancers of the lung</article-title>. <source>Integr Cancer Ther</source><year>2003</year>; <volume>2</volume>(<issue>3</issue>):<fpage>238</fpage>-<lpage>46</lpage>; PMID:15035887; http://dx.doi.org/<pub-id pub-id-type="doi">10.1177/1534735403256332</pub-id><pub-id pub-id-type="pmid">15035887</pub-id></mixed-citation></ref><ref id="cit0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Auwera</surname><given-names>I</given-names></name>, <name><surname>Van Laere</surname><given-names>SJ</given-names></name>, <name><surname>Van den Eynden</surname><given-names>GG</given-names></name>, <name><surname>Benoy</surname><given-names>I</given-names></name>, <name><surname>van Dam</surname><given-names>P</given-names></name>, <name><surname>Colpaert</surname><given-names>CG</given-names></name>, <name><surname>Fox</surname><given-names>SB</given-names></name>, <name><surname>Turley</surname><given-names>H</given-names></name>, <name><surname>Harris</surname><given-names>AL</given-names></name>, <name><surname>Van Marck</surname><given-names>EA</given-names></name>, et al.</person-group><article-title>Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification</article-title>. <source>Clin Cancer Res</source><year>2004</year>; <volume>10</volume>(<issue>23</issue>):<fpage>7965</fpage>-<lpage>71</lpage>; PMID:15585631; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0063</pub-id><pub-id pub-id-type="pmid">15585631</pub-id></mixed-citation></ref><ref id="cit0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaiswal</surname><given-names>M</given-names></name>, <name><surname>LaRusso</surname><given-names>NF</given-names></name>, <name><surname>Gores</surname><given-names>GJ</given-names></name></person-group>. <article-title>Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source><year>2001</year>; <volume>281</volume>(<issue>3</issue>):<fpage>G626</fpage>-<lpage>34</lpage>; PMID:11518674<pub-id pub-id-type="pmid">11518674</pub-id></mixed-citation></ref><ref id="cit0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>V</given-names></name></person-group>. <article-title>Researchers attempting to define role of cytokines in cancer risk</article-title>. <source>J Natl Cancer Inst</source><year>2005</year>; <volume>97</volume>(<issue>16</issue>):<fpage>1175</fpage>-<lpage>7</lpage>; PMID:16106019; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/jnci/dji269</pub-id><pub-id pub-id-type="pmid">16106019</pub-id></mixed-citation></ref><ref id="cit0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biarc</surname><given-names>J</given-names></name>, <name><surname>Nguyen</surname><given-names>IS</given-names></name>, <name><surname>Pini</surname><given-names>A</given-names></name>, <name><surname>Gossé</surname><given-names>F</given-names></name>, <name><surname>Richert</surname><given-names>S</given-names></name>, <name><surname>Thiersé</surname><given-names>D</given-names></name>, <name><surname>Van Dorsselaer</surname><given-names>A</given-names></name>, <name><surname>Leize-Wagner</surname><given-names>E</given-names></name>, <name><surname>Raul</surname><given-names>F</given-names></name>, <name><surname>Klein</surname><given-names>JP</given-names></name>, et al.</person-group><article-title>Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis)</article-title>. <source>Carcinogenesis</source><year>2004</year>; <volume>25</volume>(<issue>8</issue>):<fpage>1477</fpage>-<lpage>84</lpage>; PMID:14742316; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/carcin/bgh091</pub-id><pub-id pub-id-type="pmid">14742316</pub-id></mixed-citation></ref><ref id="cit0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altinoz</surname><given-names>MA</given-names></name>, <name><surname>Korkmaz</surname><given-names>R</given-names></name></person-group>. <article-title>NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer</article-title>. <source>Neoplasma</source><year>2004</year>; <volume>51</volume>(<issue>4</issue>):<fpage>239</fpage>-<lpage>47</lpage>; PMID:15254653<pub-id pub-id-type="pmid">15254653</pub-id></mixed-citation></ref><ref id="cit0028"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Bergh</surname><given-names>A</given-names></name>, <name><surname>Damber</surname><given-names>JE</given-names></name></person-group>. <article-title>Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium</article-title>. <source>Prostate</source><year>2004</year>; <volume>61</volume>(<issue>1</issue>):<fpage>60</fpage>-<lpage>72</lpage>; PMID:15287094; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/pros.20061</pub-id><pub-id pub-id-type="pmid">15287094</pub-id></mixed-citation></ref><ref id="cit0029"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>MR</given-names></name>, <name><surname>Ahmed</surname><given-names>RA</given-names></name></person-group>. <article-title>Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin</article-title>. <source>Cancer Biol Ther</source><year>2005</year>; <volume>4</volume>(<issue>8</issue>):<fpage>819</fpage>-<lpage>21</lpage>; PMID:16210913; http://dx.doi.org/<pub-id pub-id-type="doi">10.4161/cbt.4.8.1864</pub-id><pub-id pub-id-type="pmid">16210913</pub-id></mixed-citation></ref><ref id="cit0030"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartsch</surname><given-names>H</given-names></name>, <name><surname>Nair</surname><given-names>J</given-names></name></person-group>. <article-title>Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis</article-title>. <source>Cancer Detect Prev</source><year>2004</year>; <volume>28</volume>(<issue>6</issue>):<fpage>385</fpage>-<lpage>91</lpage>; PMID:15582261; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.cdp.2004.07.004</pub-id><pub-id pub-id-type="pmid">15582261</pub-id></mixed-citation></ref><ref id="cit0031"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelo</surname><given-names>LS</given-names></name>, <name><surname>Kurzrock</surname><given-names>R</given-names></name></person-group>. <article-title>Vascular endothelial growth factor and its relationship to inflammatory mediators</article-title>. <source>Clin Cancer Res</source><year>2007</year>; <volume>13</volume>(<issue>10</issue>):<fpage>2825</fpage>-<lpage>30</lpage>; PMID:17504979; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-2416</pub-id><pub-id pub-id-type="pmid">17504979</pub-id></mixed-citation></ref><ref id="cit0032"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>RK</given-names></name></person-group>. <article-title>Barriers to drug delivery in solid tumors</article-title>. <source>Sci Am</source><year>1994</year>; <volume>271</volume>(<issue>1</issue>):<fpage>58</fpage>-<lpage>65</lpage>; PMID:8066425; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/scientificamerican0794-58</pub-id><pub-id pub-id-type="pmid">8066425</pub-id></mixed-citation></ref><ref id="cit0033"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padera</surname><given-names>TP</given-names></name>, <name><surname>Kadambi</surname><given-names>A</given-names></name>, <name><surname>di Tomaso</surname><given-names>E</given-names></name>, <name><surname>Carreira</surname><given-names>CM</given-names></name>, <name><surname>Brown</surname><given-names>EB</given-names></name>, <name><surname>Boucher</surname><given-names>Y</given-names></name>, <name><surname>Choi</surname><given-names>NC</given-names></name>, <name><surname>Mathisen</surname><given-names>D</given-names></name>, <name><surname>Wain</surname><given-names>J</given-names></name>, <name><surname>Mark</surname><given-names>EJ</given-names></name>, et al.</person-group><article-title>Lymphatic metastasis in the absence of functional intratumor lymphatics</article-title>. <source>Science</source><year>2002</year>; <volume>296</volume>(<issue>5574</issue>):<fpage>1883</fpage>-<lpage>6</lpage>; PMID:11976409; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.1071420</pub-id><pub-id pub-id-type="pmid">11976409</pub-id></mixed-citation></ref><ref id="cit0034"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dadras</surname><given-names>SS</given-names></name>, <name><surname>Lange-Asschenfeldt</surname><given-names>B</given-names></name>, <name><surname>Velasco</surname><given-names>P</given-names></name>, <name><surname>Nguyen</surname><given-names>L</given-names></name>, <name><surname>Vora</surname><given-names>A</given-names></name>, <name><surname>Muzikansky</surname><given-names>A</given-names></name>, <name><surname>Jahnke</surname><given-names>K</given-names></name>, <name><surname>Hauschild</surname><given-names>A</given-names></name>, <name><surname>Hirakawa</surname><given-names>S</given-names></name>, <name><surname>Mihm</surname><given-names>MC</given-names></name>, et al.</person-group><article-title>Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes</article-title>. <source>Mod Pathol</source><year>2005</year>; <volume>18</volume>(<issue>9</issue>):<fpage>1232</fpage>-<lpage>42</lpage>; PMID:15803182; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/modpathol.3800410</pub-id><pub-id pub-id-type="pmid">15803182</pub-id></mixed-citation></ref><ref id="cit0035"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maula</surname><given-names>SM</given-names></name>, <name><surname>Luukkaa</surname><given-names>M</given-names></name>, <name><surname>Grenman</surname><given-names>R</given-names></name>, <name><surname>Jackson</surname><given-names>D</given-names></name>, <name><surname>Jalkanen</surname><given-names>S</given-names></name>, <name><surname>Ristamaki</surname><given-names>R</given-names></name></person-group>. <article-title>Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region</article-title>. <source>Cancer Res</source><year>2003</year>; <volume>63</volume>(<issue>8</issue>):<fpage>1920</fpage>-<lpage>6</lpage>; PMID:12702584<pub-id pub-id-type="pmid">12702584</pub-id></mixed-citation></ref><ref id="cit0036"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>WW</given-names></name>, <name><surname>Lewis</surname><given-names>MM</given-names></name>, <name><surname>Lawson</surname><given-names>D</given-names></name>, <name><surname>Yin-Goen</surname><given-names>Q</given-names></name>, <name><surname>Birdsong</surname><given-names>GG</given-names></name>, <name><surname>Cotsonis</surname><given-names>GA</given-names></name>, <name><surname>Cohen</surname><given-names>C</given-names></name>, <name><surname>Young</surname><given-names>AN</given-names></name></person-group>. <article-title>Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression</article-title>. <source>Mod Pathol</source><year>2005</year>; <volume>18</volume>(<issue>1</issue>):<fpage>143</fpage>-<lpage>52</lpage>; PMID:15297858; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/modpathol.3800253</pub-id><pub-id pub-id-type="pmid">15297858</pub-id></mixed-citation></ref><ref id="cit0037"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergers</surname><given-names>G</given-names></name>, <name><surname>Benjamin</surname><given-names>LE</given-names></name></person-group>. <article-title>Tumorigenesis and the angiogenic switch</article-title>. <source>Nat Rev Cancer</source><year>2003</year>; <volume>3</volume>(<issue>6</issue>):<fpage>401</fpage>-<lpage>10</lpage>; PMID:12778130; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nrc1093</pub-id><pub-id pub-id-type="pmid">12778130</pub-id></mixed-citation></ref><ref id="cit0038"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skobe</surname><given-names>M</given-names></name>, <name><surname>Hawighorst</surname><given-names>T</given-names></name>, <name><surname>Jackson</surname><given-names>DG</given-names></name>, <name><surname>Prevo</surname><given-names>R</given-names></name>, <name><surname>Janes</surname><given-names>L</given-names></name>, <name><surname>Velasco</surname><given-names>P</given-names></name>, <name><surname>Riccardi</surname><given-names>L</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name>, <name><surname>Claffey</surname><given-names>K</given-names></name>, <name><surname>Detmar</surname><given-names>M</given-names></name></person-group>. <article-title>Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis</article-title>. <source>Nat Med</source><year>2001</year>; <volume>7</volume>(<issue>2</issue>):<fpage>192</fpage>-<lpage>8</lpage>; PMID:11175850; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/84643</pub-id><pub-id pub-id-type="pmid">11175850</pub-id></mixed-citation></ref><ref id="cit0039"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacker</surname><given-names>SA</given-names></name>, <name><surname>Caesar</surname><given-names>C</given-names></name>, <name><surname>Baldwin</surname><given-names>ME</given-names></name>, <name><surname>Thornton</surname><given-names>GE</given-names></name>, <name><surname>Williams</surname><given-names>RA</given-names></name>, <name><surname>Prevo</surname><given-names>R</given-names></name>, <name><surname>Jackson</surname><given-names>DG</given-names></name>, <name><surname>Nishikawa</surname><given-names>S</given-names></name>, <name><surname>Kubo</surname><given-names>H</given-names></name>, <name><surname>Achen</surname><given-names>MG</given-names></name></person-group>. <article-title>VEGF-D promotes the metastatic spread of tumor cells via the lymphatics</article-title>. <source>Nat Med</source><year>2001</year>; <volume>7</volume>(<issue>2</issue>):<fpage>186</fpage>-<lpage>91</lpage>; PMID:11175849; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/84635</pub-id><pub-id pub-id-type="pmid">11175849</pub-id></mixed-citation></ref><ref id="cit0040"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrova</surname><given-names>TV</given-names></name>, <name><surname>Makinen</surname><given-names>T</given-names></name>, <name><surname>Makela</surname><given-names>TP</given-names></name>, <name><surname>Saarela</surname><given-names>J</given-names></name>, <name><surname>Virtanen</surname><given-names>I</given-names></name>, <name><surname>Ferrell</surname><given-names>RE</given-names></name>, <name><surname>Finegold</surname><given-names>DN</given-names></name>, <name><surname>Kerjaschki</surname><given-names>D</given-names></name>, <name><surname>Ylä-Herttuala</surname><given-names>S</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name></person-group>. <article-title>Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor</article-title>. <source>Embo J</source><year>2002</year>; <volume>21</volume>(<issue>17</issue>):<fpage>4593</fpage>-<lpage>9</lpage>; PMID:12198161; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/emboj/cdf470</pub-id><pub-id pub-id-type="pmid">12198161</pub-id></mixed-citation></ref><ref id="cit0041"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tal</surname><given-names>O</given-names></name>, <name><surname>Lim</surname><given-names>HY</given-names></name>, <name><surname>Gurevich</surname><given-names>I</given-names></name>, <name><surname>Milo</surname><given-names>I</given-names></name>, <name><surname>Shipony</surname><given-names>Z</given-names></name>, <name><surname>Ng</surname><given-names>LG</given-names></name>, <name><surname>Angeli</surname><given-names>V</given-names></name>, <name><surname>Shakhar</surname><given-names>G</given-names></name></person-group>. <article-title>DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling</article-title>. <source>J Exp Med</source><year>2011</year>; <volume>208</volume>(<issue>10</issue>):<fpage>2141</fpage>-<lpage>53</lpage>; PMID:21930767; http://dx.doi.org/<pub-id pub-id-type="doi">10.1084/jem.20102392</pub-id><pub-id pub-id-type="pmid">21930767</pub-id></mixed-citation></ref><ref id="cit0042"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Issa</surname><given-names>A</given-names></name>, <name><surname>Le</surname><given-names>TX</given-names></name>, <name><surname>Shoushtari</surname><given-names>AN</given-names></name>, <name><surname>Shields</surname><given-names>JD</given-names></name>, <name><surname>Swartz</surname><given-names>MA</given-names></name></person-group>. <article-title>Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype</article-title>. <source>Cancer Res</source><year>2009</year>; <volume>69</volume>(<issue>1</issue>):<fpage>349</fpage>-<lpage>57</lpage>; PMID:19118020; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1875</pub-id><pub-id pub-id-type="pmid">19118020</pub-id></mixed-citation></ref><ref id="cit0043"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanovic</surname><given-names>Z</given-names></name></person-group>. <article-title>Hypoxia or in situ normoxia: The stem cell paradigm</article-title>. <source>J Cell Physiol</source><year>2009</year>; <volume>219</volume>(<issue>2</issue>):<fpage>271</fpage>-<lpage>5</lpage>; PMID:19160417; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/jcp.21690</pub-id><pub-id pub-id-type="pmid">19160417</pub-id></mixed-citation></ref><ref id="cit0044"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzy</surname><given-names>RD</given-names></name>, <name><surname>Sharma</surname><given-names>B</given-names></name>, <name><surname>Bell</surname><given-names>E</given-names></name>, <name><surname>Chandel</surname><given-names>NS</given-names></name>, <name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group>. <article-title>Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis</article-title>. <source>Mol Cell Biol</source><year>2008</year>; <volume>28</volume>(<issue>2</issue>):<fpage>718</fpage>-<lpage>31</lpage>; PMID:17967865; http://dx.doi.org/<pub-id pub-id-type="doi">10.1128/MCB.01338-07</pub-id><pub-id pub-id-type="pmid">17967865</pub-id></mixed-citation></ref><ref id="cit0045"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morfoisse</surname><given-names>F</given-names></name>, <name><surname>Kuchnio</surname><given-names>A</given-names></name>, <name><surname>Frainay</surname><given-names>C</given-names></name>, <name><surname>Gomez-Brouchet</surname><given-names>A</given-names></name>, <name><surname>Delisle</surname><given-names>MB</given-names></name>, <name><surname>Marzi</surname><given-names>S</given-names></name>, <name><surname>Helfer</surname><given-names>AC</given-names></name>, <name><surname>Hantelys</surname><given-names>F</given-names></name>, <name><surname>Pujol</surname><given-names>F</given-names></name>, <name><surname>Guillermet-Guibert</surname><given-names>J</given-names></name>, et al.</person-group><article-title>Hypoxia induces VEGF-C expression in metastatic Tumor cells via a HIF-1alpha-independent translation-mediated mechanism</article-title>. <source>Cell reports</source><year>2014</year>; <volume>6</volume>(<issue>1</issue>):<fpage>155</fpage>-<lpage>67</lpage>; PMID:24388748; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.celrep.2013.12.011</pub-id><pub-id pub-id-type="pmid">24388748</pub-id></mixed-citation></ref><ref id="cit0046"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanovic</surname><given-names>Z</given-names></name></person-group>. <article-title>Physiological, ex vivo cell oxygenation is necessary for a true insight into cytokine biology</article-title>. <source>Eur Cytokine Netw</source><year>2009</year>; <volume>20</volume>(<issue>1</issue>):<fpage>7</fpage>-<lpage>9</lpage>; PMID:19318314<pub-id pub-id-type="pmid">19318314</pub-id></mixed-citation></ref><ref id="cit0047"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>HP</given-names></name>, <name><surname>Condorelli</surname><given-names>F</given-names></name>, <name><surname>Park</surname><given-names>J</given-names></name>, <name><surname>Ferrara</surname><given-names>N</given-names></name></person-group>. <article-title>Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia</article-title>. <source>J Biol Chem</source><year>1997</year>; <volume>272</volume>(<issue>38</issue>):<fpage>23659</fpage>-<lpage>67</lpage>; PMID:9295307; http://dx.doi.org/<pub-id pub-id-type="doi">10.1074/jbc.272.38.23659</pub-id><pub-id pub-id-type="pmid">9295307</pub-id></mixed-citation></ref><ref id="cit0048"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>NV</given-names></name>, <name><surname>Kotch</surname><given-names>LE</given-names></name>, <name><surname>Agani</surname><given-names>F</given-names></name>, <name><surname>Leung</surname><given-names>SW</given-names></name>, <name><surname>Laughner</surname><given-names>E</given-names></name>, <name><surname>Wenger</surname><given-names>RH</given-names></name>, <name><surname>Gassmann</surname><given-names>M</given-names></name>, <name><surname>Gearhart</surname><given-names>JD</given-names></name>, <name><surname>Lawler</surname><given-names>AM</given-names></name>, <name><surname>Yu</surname><given-names>AY</given-names></name>, et al.</person-group><article-title>Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha</article-title>. <source>Genes Dev</source><year>1998</year>; <volume>12</volume>(<issue>2</issue>):<fpage>149</fpage>-<lpage>62</lpage>; PMID:9436976; http://dx.doi.org/<pub-id pub-id-type="doi">10.1101/gad.12.2.149</pub-id><pub-id pub-id-type="pmid">9436976</pub-id></mixed-citation></ref><ref id="cit0049"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>HE</given-names></name>, <name><surname>Lo</surname><given-names>J</given-names></name>, <name><surname>Johnson</surname><given-names>RS</given-names></name></person-group>. <article-title>HIF-1 alpha is required for solid tumor formation and embryonic vascularization</article-title>. <source>Embo J</source><year>1998</year>; <volume>17</volume>(<issue>11</issue>):<fpage>3005</fpage>-<lpage>15</lpage>; PMID:9606183; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/emboj/17.11.3005</pub-id><pub-id pub-id-type="pmid">9606183</pub-id></mixed-citation></ref><ref id="cit0050"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>LE</given-names></name>, <name><surname>Gu</surname><given-names>J</given-names></name>, <name><surname>Schau</surname><given-names>M</given-names></name>, <name><surname>Bunn</surname><given-names>HF</given-names></name></person-group>. <article-title>Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway</article-title>. <source>Proc Natl Acad Sci U S A</source><year>1998</year>; <volume>95</volume>(<issue>14</issue>):<fpage>7987</fpage>-<lpage>92</lpage>; PMID:9653127; http://dx.doi.org/<pub-id pub-id-type="doi">10.1073/pnas.95.14.7987</pub-id><pub-id pub-id-type="pmid">9653127</pub-id></mixed-citation></ref><ref id="cit0051"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruick</surname><given-names>RK</given-names></name>, <name><surname>McKnight</surname><given-names>SL</given-names></name></person-group>. <article-title>A conserved family of prolyl-4-hydroxylases that modify HIF</article-title>. <source>Science</source><year>2001</year>; <volume>294</volume>(<issue>5545</issue>):<fpage>1337</fpage>-<lpage>40</lpage>; PMID:11598268; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.1066373</pub-id><pub-id pub-id-type="pmid">11598268</pub-id></mixed-citation></ref><ref id="cit0052"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzone</surname><given-names>M</given-names></name>, <name><surname>Dettori</surname><given-names>D</given-names></name>, <name><surname>Leite de Oliveira</surname><given-names>R</given-names></name>, <name><surname>Loges</surname><given-names>S</given-names></name>, <name><surname>Schmidt</surname><given-names>T</given-names></name>, <name><surname>Jonckx</surname><given-names>B</given-names></name>, <name><surname>Tian</surname><given-names>YM</given-names></name>, <name><surname>Lanahan</surname><given-names>AA</given-names></name>, <name><surname>Pollard</surname><given-names>P</given-names></name>, <name><surname>Ruiz de Almodovar</surname><given-names>C</given-names></name>, et al.</person-group><article-title>Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization</article-title>. <source>Cell</source><year>2009</year>; <volume>136</volume>(<issue>5</issue>):<fpage>839</fpage>-<lpage>51</lpage>; PMID:19217150; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.cell.2009.01.020</pub-id><pub-id pub-id-type="pmid">19217150</pub-id></mixed-citation></ref><ref id="cit0053"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaakkola</surname><given-names>P</given-names></name>, <name><surname>Mole</surname><given-names>DR</given-names></name>, <name><surname>Tian</surname><given-names>YM</given-names></name>, <name><surname>Wilson</surname><given-names>MI</given-names></name>, <name><surname>Gielbert</surname><given-names>J</given-names></name>, <name><surname>Gaskell</surname><given-names>SJ</given-names></name>, <name><surname>von Kriegsheim</surname><given-names>A</given-names></name>, <name><surname>Hebestreit</surname><given-names>HF</given-names></name>, <name><surname>Mukherji</surname><given-names>M</given-names></name>, <name><surname>Schofield</surname><given-names>CJ</given-names></name>, et al.</person-group><article-title>Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation</article-title>. <source>Science</source><year>2001</year>; <volume>292</volume>(<issue>5516</issue>):<fpage>468</fpage>-<lpage>72</lpage>; PMID:11292861; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.1059796</pub-id><pub-id pub-id-type="pmid">11292861</pub-id></mixed-citation></ref><ref id="cit0054"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivan</surname><given-names>M</given-names></name>, <name><surname>Kondo</surname><given-names>K</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>W</given-names></name>, <name><surname>Valiando</surname><given-names>J</given-names></name>, <name><surname>Ohh</surname><given-names>M</given-names></name>, <name><surname>Salic</surname><given-names>A</given-names></name>, <name><surname>Asara</surname><given-names>JM</given-names></name>, <name><surname>Lane</surname><given-names>WS</given-names></name>, <name><surname>Kaelin</surname><given-names>WG</given-names><suffix>Jr</suffix></name></person-group>. <article-title>HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing</article-title>. <source>Science</source><year>2001</year>; <volume>292</volume>(<issue>5516</issue>):<fpage>464</fpage>-<lpage>8</lpage>; PMID:11292862; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.1059817</pub-id><pub-id pub-id-type="pmid">11292862</pub-id></mixed-citation></ref><ref id="cit0055"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>N</given-names></name></person-group>. <article-title>Vascular endothelial growth factor as a target for anticancer therapy</article-title>. <source>Oncologist</source><year>2004</year>; <volume>9</volume>(<issue>Suppl 1</issue>):<fpage>2</fpage>-<lpage>10</lpage>; PMID:15178810; http://dx.doi.org/<pub-id pub-id-type="doi">10.1634/theoncologist.9-suppl_1-2</pub-id><pub-id pub-id-type="pmid">15178810</pub-id></mixed-citation></ref><ref id="cit0056"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pages</surname><given-names>G</given-names></name>, <name><surname>Pouyssegur</surname><given-names>J</given-names></name></person-group>. <article-title>Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors</article-title>. <source>Cardiovasc Res</source><year>2005</year>; <volume>65</volume>(<issue>3</issue>):<fpage>564</fpage>-<lpage>73</lpage>; PMID:15664382; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.cardiores.2004.09.032</pub-id><pub-id pub-id-type="pmid">15664382</pub-id></mixed-citation></ref><ref id="cit0057"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>JA</given-names></name>, <name><surname>Jiang</surname><given-names>BH</given-names></name>, <name><surname>Iyer</surname><given-names>NV</given-names></name>, <name><surname>Agani</surname><given-names>F</given-names></name>, <name><surname>Leung</surname><given-names>SW</given-names></name>, <name><surname>Koos</surname><given-names>RD</given-names></name>, <name><surname>Semenza</surname><given-names>GL</given-names></name></person-group>. <article-title>Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</article-title>. <source>Mol Cell Biol</source><year>1996</year>; <volume>16</volume>(<issue>9</issue>):<fpage>4604</fpage>-<lpage>13</lpage>; PMID:8756616<pub-id pub-id-type="pmid">8756616</pub-id></mixed-citation></ref><ref id="cit0058"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blancher</surname><given-names>C</given-names></name>, <name><surname>Moore</surname><given-names>JW</given-names></name>, <name><surname>Talks</surname><given-names>KL</given-names></name>, <name><surname>Houlbrook</surname><given-names>S</given-names></name>, <name><surname>Harris</surname><given-names>AL</given-names></name></person-group>. <article-title>Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines</article-title>. <source>Cancer Res</source><year>2000</year>; <volume>60</volume>(<issue>24</issue>):<fpage>7106</fpage>-<lpage>13</lpage>; PMID:11156418<pub-id pub-id-type="pmid">11156418</pub-id></mixed-citation></ref><ref id="cit0059"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname><given-names>AR</given-names></name>, <name><surname>Fallmann</surname><given-names>J</given-names></name>, <name><surname>Kratochvill</surname><given-names>F</given-names></name>, <name><surname>Kovarik</surname><given-names>P</given-names></name>, <name><surname>Hofacker</surname><given-names>IL</given-names></name></person-group>. <article-title>AREsite: a database for the comprehensive investigation of AU-rich elements</article-title>. <source>Nucleic Acids Res</source><year>2011</year>; <volume>39</volume>(<issue>Database issue</issue>):<fpage>D66</fpage>-<lpage>9</lpage>; PMID:21071424; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/nar/gkq990</pub-id><pub-id pub-id-type="pmid">21071424</pub-id></mixed-citation></ref><ref id="cit0060"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>AP</given-names></name>, <name><surname>Levy</surname><given-names>NS</given-names></name>, <name><surname>Goldberg</surname><given-names>MA</given-names></name></person-group>. <article-title>Post-transcriptional regulation of vascular endothelial growth factor by hypoxia</article-title>. <source>J Biol Chem</source><year>1996</year>; <volume>271</volume>(<issue>5</issue>):<fpage>2746</fpage>-<lpage>53</lpage>; PMID:8576250; http://dx.doi.org/<pub-id pub-id-type="doi">10.1074/jbc.271.5.2746</pub-id><pub-id pub-id-type="pmid">8576250</pub-id></mixed-citation></ref><ref id="cit0061"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griseri</surname><given-names>P</given-names></name>, <name><surname>Pages</surname><given-names>G</given-names></name></person-group>. <article-title>Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins</article-title>. <source>J Interferon Cytokine Res</source><year>2014</year>; <volume>34</volume>(<issue>4</issue>):<fpage>242</fpage>-<lpage>54</lpage>; PMID:24697202; http://dx.doi.org/<pub-id pub-id-type="doi">10.1089/jir.2013.0140</pub-id><pub-id pub-id-type="pmid">24697202</pub-id></mixed-citation></ref><ref id="cit0062"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onesto</surname><given-names>C</given-names></name>, <name><surname>Berra</surname><given-names>E</given-names></name>, <name><surname>Grepin</surname><given-names>R</given-names></name>, <name><surname>Pages</surname><given-names>G</given-names></name></person-group>. <article-title>Poly(A)-binding protein-interacting protein 2, a strong regulator of vascular endothelial growth factor mRNA</article-title>. <source>J Biol Chem</source><year>2004</year>; <volume>279</volume>(<issue>33</issue>):<fpage>34217</fpage>-<lpage>26</lpage>; PMID:15175342; http://dx.doi.org/<pub-id pub-id-type="doi">10.1074/jbc.M400219200</pub-id><pub-id pub-id-type="pmid">15175342</pub-id></mixed-citation></ref><ref id="cit0063"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>SH</given-names></name>, <name><surname>Hla</surname><given-names>T</given-names></name></person-group>. <article-title>Post-transcriptional gene regulation by HuR and microRNAs in angiogenesis</article-title>. <source>Curr Opin Hematol</source><year>2014</year>; <volume>21</volume>(<issue>3</issue>):<fpage>235</fpage>-<lpage>40</lpage>; PMID:24714527; http://dx.doi.org/<pub-id pub-id-type="doi">10.1097/MOH.0000000000000040</pub-id><pub-id pub-id-type="pmid">24714527</pub-id></mixed-citation></ref><ref id="cit0064"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holcik</surname><given-names>M</given-names></name>, <name><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>. <article-title>Translational control in stress and apoptosis</article-title>. <source>Nat Rev Mol Cell Biol</source><year>2005</year>; <volume>6</volume>(<issue>4</issue>):<fpage>318</fpage>-<lpage>27</lpage>; PMID:15803138; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nrm1618</pub-id><pub-id pub-id-type="pmid">15803138</pub-id></mixed-citation></ref><ref id="cit0065"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>SD</given-names></name>, <name><surname>Turcotte</surname><given-names>M</given-names></name>, <name><surname>Korneluk</surname><given-names>RG</given-names></name>, <name><surname>Holcik</surname><given-names>M</given-names></name></person-group>. <article-title>Searching for IRES</article-title>. <source>RNA</source><year>2006</year>; <volume>12</volume>(<issue>10</issue>):<fpage>1755</fpage>-<lpage>85</lpage>; PMID:16957278; http://dx.doi.org/<pub-id pub-id-type="doi">10.1261/rna.157806</pub-id><pub-id pub-id-type="pmid">16957278</pub-id></mixed-citation></ref><ref id="cit0066"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silvera</surname><given-names>D</given-names></name>, <name><surname>Schneider</surname><given-names>RJ</given-names></name></person-group>. <article-title>Inflammatory breast cancer cells are constitutively adapted to hypoxia</article-title>. <source>Cell Cycle</source><year>2009</year>; <volume>8</volume>(<issue>19</issue>):<fpage>3091</fpage>-<lpage>6</lpage>; PMID:19755858; http://dx.doi.org/<pub-id pub-id-type="doi">10.4161/cc.8.19.9637</pub-id><pub-id pub-id-type="pmid">19755858</pub-id></mixed-citation></ref><ref id="cit0067"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somers</surname><given-names>J</given-names></name>, <name><surname>Poyry</surname><given-names>T</given-names></name>, <name><surname>Willis</surname><given-names>AE</given-names></name></person-group>. <article-title>A perspective on mammalian upstream open reading frame function</article-title>. <source>Int J Biochem Cell Biol</source><year>2013</year>; <volume>45</volume>(<issue>8</issue>):<fpage>1690</fpage>-<lpage>700</lpage>; PMID:23624144; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.biocel.2013.04.020</pub-id><pub-id pub-id-type="pmid">23624144</pub-id></mixed-citation></ref><ref id="cit0068"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagner</surname><given-names>S</given-names></name>, <name><surname>Galy</surname><given-names>B</given-names></name>, <name><surname>Pyronnet</surname><given-names>S</given-names></name></person-group>. <article-title>Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites</article-title>. <source>EMBO Rep</source><year>2001</year>; <volume>2</volume>(<issue>10</issue>):<fpage>893</fpage>-<lpage>8</lpage>; PMID:11600453; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/embo-reports/kve208</pub-id><pub-id pub-id-type="pmid">11600453</pub-id></mixed-citation></ref><ref id="cit0069"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bushell</surname><given-names>M</given-names></name>, <name><surname>Stoneley</surname><given-names>M</given-names></name>, <name><surname>Sarnow</surname><given-names>P</given-names></name>, <name><surname>Willis</surname><given-names>AE</given-names></name></person-group>. <article-title>Translation inhibition during the induction of apoptosis: RNA or protein degradation?</article-title><source>Biochem Soc Trans</source><year>2004</year>; <volume>32</volume>(<issue>Pt 4</issue>):<fpage>606</fpage>-<lpage>10</lpage>; PMID:15270687<pub-id pub-id-type="pmid">15270687</pub-id></mixed-citation></ref><ref id="cit0070"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakor</surname><given-names>N</given-names></name>, <name><surname>Holcik</surname><given-names>M</given-names></name></person-group>. <article-title>IRES-mediated translation of cellular messenger RNA operates in eIF2alpha- independent manner during stress</article-title>. <source>Nucleic Acids Res</source><year>2012</year>; <volume>40</volume>(<issue>2</issue>):<fpage>541</fpage>-<lpage>52</lpage>; PMID:21917851; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/nar/gkr701</pub-id><pub-id pub-id-type="pmid">21917851</pub-id></mixed-citation></ref><ref id="cit0071"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagner</surname><given-names>S</given-names></name>, <name><surname>Gensac</surname><given-names>MC</given-names></name>, <name><surname>Maret</surname><given-names>A</given-names></name>, <name><surname>Bayard</surname><given-names>F</given-names></name>, <name><surname>Amalric</surname><given-names>F</given-names></name>, <name><surname>Prats</surname><given-names>H</given-names></name>, <name><surname>Prats</surname><given-names>AC</given-names></name></person-group>. <article-title>Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes</article-title>. <source>Mol Cell Biol</source><year>1995</year>; <volume>15</volume>(<issue>1</issue>):<fpage>35</fpage>-<lpage>44</lpage>; PMID:7799942<pub-id pub-id-type="pmid">7799942</pub-id></mixed-citation></ref><ref id="cit0072"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huez</surname><given-names>I</given-names></name>, <name><surname>Creancier</surname><given-names>L</given-names></name>, <name><surname>Audigier</surname><given-names>S</given-names></name>, <name><surname>Gensac</surname><given-names>MC</given-names></name>, <name><surname>Prats</surname><given-names>AC</given-names></name>, <name><surname>Prats</surname><given-names>H</given-names></name></person-group>. <article-title>Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA</article-title>. <source>Mol Cell Biol</source><year>1998</year>; <volume>18</volume>(<issue>11</issue>):<fpage>6178</fpage>-<lpage>90</lpage>; PMID:9774635<pub-id pub-id-type="pmid">9774635</pub-id></mixed-citation></ref><ref id="cit0073"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornes</surname><given-names>S</given-names></name>, <name><surname>Prado-Lourenco</surname><given-names>L</given-names></name>, <name><surname>Bastide</surname><given-names>A</given-names></name>, <name><surname>Zanibellato</surname><given-names>C</given-names></name>, <name><surname>Iacovoni</surname><given-names>JS</given-names></name>, <name><surname>Lacazette</surname><given-names>E</given-names></name>, <name><surname>Prats</surname><given-names>AC</given-names></name>, <name><surname>Touriol</surname><given-names>C</given-names></name>, <name><surname>Prats</surname><given-names>H</given-names></name></person-group>. <article-title>Translational induction of VEGF internal ribosome entry site elements during the early response to ischemic stress</article-title>. <source>Circ Res</source><year>2007</year>; <volume>100</volume>(<issue>3</issue>):<fpage>305</fpage>-<lpage>8</lpage>; PMID:17255526; http://dx.doi.org/<pub-id pub-id-type="doi">10.1161/01.RES.0000258873.08041.c9</pub-id><pub-id pub-id-type="pmid">17255526</pub-id></mixed-citation></ref><ref id="cit0074"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcondeguy</surname><given-names>T</given-names></name>, <name><surname>Lacazette</surname><given-names>E</given-names></name>, <name><surname>Millevoi</surname><given-names>S</given-names></name>, <name><surname>Prats</surname><given-names>H</given-names></name>, <name><surname>Touriol</surname><given-names>C</given-names></name></person-group>. <article-title>VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level</article-title>. <source>Nucleic Acids Res</source><year>2013</year>; <volume>41</volume>(<issue>17</issue>):<fpage>7997</fpage>-<lpage>8010</lpage>; PMID:23851566; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/nar/gkt539</pub-id><pub-id pub-id-type="pmid">23851566</pub-id></mixed-citation></ref><ref id="cit0075"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keck</surname><given-names>PJ</given-names></name>, <name><surname>Hauser</surname><given-names>SD</given-names></name>, <name><surname>Krivi</surname><given-names>G</given-names></name>, <name><surname>Sanzo</surname><given-names>K</given-names></name>, <name><surname>Warren</surname><given-names>T</given-names></name>, <name><surname>Feder</surname><given-names>J</given-names></name>, <name><surname>Connolly</surname><given-names>DT</given-names></name></person-group>. <article-title>Vascular permeability factor, an endothelial cell mitogen related to PDGF</article-title>. <source>Science</source><year>1989</year>; <volume>246</volume>(<issue>4935</issue>):<fpage>1309</fpage>-<lpage>12</lpage>; PMID:2479987; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.2479987</pub-id><pub-id pub-id-type="pmid">2479987</pub-id></mixed-citation></ref><ref id="cit0076"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>DW</given-names></name>, <name><surname>Cachianes</surname><given-names>G</given-names></name>, <name><surname>Kuang</surname><given-names>WJ</given-names></name>, <name><surname>Goeddel</surname><given-names>DV</given-names></name>, <name><surname>Ferrara</surname><given-names>N</given-names></name></person-group>. <article-title>Vascular endothelial growth factor is a secreted angiogenic mitogen</article-title>. <source>Science</source><year>1989</year>; <volume>246</volume>(<issue>4935</issue>):<fpage>1306</fpage>-<lpage>9</lpage>; PMID:2479986; http://dx.doi.org/<pub-id pub-id-type="doi">10.1126/science.2479986</pub-id><pub-id pub-id-type="pmid">2479986</pub-id></mixed-citation></ref><ref id="cit0077"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tischer</surname><given-names>E</given-names></name>, <name><surname>Mitchell</surname><given-names>R</given-names></name>, <name><surname>Hartman</surname><given-names>T</given-names></name>, <name><surname>Silva</surname><given-names>M</given-names></name>, <name><surname>Gospodarowicz</surname><given-names>D</given-names></name>, <name><surname>Fiddes</surname><given-names>JC</given-names></name>, <name><surname>Abraham</surname><given-names>JA</given-names></name></person-group>. <article-title>The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing</article-title>. <source>J Biol Chem</source><year>1991</year>; <volume>266</volume>(<issue>18</issue>):<fpage>11947</fpage>-<lpage>54</lpage>; PMID:1711045<pub-id pub-id-type="pmid">1711045</pub-id></mixed-citation></ref><ref id="cit0078"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houck</surname><given-names>KA</given-names></name>, <name><surname>Leung</surname><given-names>DW</given-names></name>, <name><surname>Rowland</surname><given-names>AM</given-names></name>, <name><surname>Winer</surname><given-names>J</given-names></name>, <name><surname>Ferrara</surname><given-names>N</given-names></name></person-group>. <article-title>Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms</article-title>. <source>J Biol Chem</source><year>1992</year>; <volume>267</volume>(<issue>36</issue>):<fpage>26031</fpage>-<lpage>7</lpage>; PMID:1464614<pub-id pub-id-type="pmid">1464614</pub-id></mixed-citation></ref><ref id="cit0079"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group>. <article-title>Angiogenesis in life, disease and medicine</article-title>. <source>Nature</source><year>2005</year>; <volume>438</volume>(<issue>7070</issue>):<fpage>932</fpage>-<lpage>6</lpage>; PMID:16355210; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature04478</pub-id><pub-id pub-id-type="pmid">16355210</pub-id></mixed-citation></ref><ref id="cit0080"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>MT</given-names></name>, <name><surname>Brekken</surname><given-names>RA</given-names></name></person-group>. <article-title>Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium</article-title>. <source>PLoS One</source><year>2011</year>; <volume>6</volume>(<issue>12</issue>):<fpage>e28947</fpage>; PMID:22174934; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0028947</pub-id><pub-id pub-id-type="pmid">22174934</pub-id></mixed-citation></ref><ref id="cit0081"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuest</surname><given-names>TR</given-names></name>, <name><surname>Carr</surname><given-names>DJ</given-names></name></person-group>. <article-title>VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis</article-title>. <source>J Exp Med</source><year>2010</year>; <volume>207</volume>(<issue>1</issue>):<fpage>101</fpage>-<lpage>15</lpage>; PMID:20026662; http://dx.doi.org/<pub-id pub-id-type="doi">10.1084/jem.20091385</pub-id><pub-id pub-id-type="pmid">20026662</pub-id></mixed-citation></ref><ref id="cit0082"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastide</surname><given-names>A</given-names></name>, <name><surname>Karaa</surname><given-names>Z</given-names></name>, <name><surname>Bornes</surname><given-names>S</given-names></name>, <name><surname>Hieblot</surname><given-names>C</given-names></name>, <name><surname>Lacazette</surname><given-names>E</given-names></name>, <name><surname>Prats</surname><given-names>H</given-names></name>, <name><surname>Touriol</surname><given-names>C</given-names></name></person-group>. <article-title>An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform</article-title>. <source>Nucleic Acids Res</source><year>2008</year>; <volume>36</volume>(<issue>7</issue>):<fpage>2434</fpage>-<lpage>45</lpage>; PMID:18304943; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/nar/gkn093</pub-id><pub-id pub-id-type="pmid">18304943</pub-id></mixed-citation></ref><ref id="cit0083"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaa</surname><given-names>ZS</given-names></name>, <name><surname>Iacovoni</surname><given-names>JS</given-names></name>, <name><surname>Bastide</surname><given-names>A</given-names></name>, <name><surname>Lacazette</surname><given-names>E</given-names></name>, <name><surname>Touriol</surname><given-names>C</given-names></name>, <name><surname>Prats</surname><given-names>H</given-names></name></person-group>. <article-title>The VEGF IRESes are differentially susceptible to translation inhibition by miR-16</article-title>. <source>RNA</source><year>2009</year>; <volume>15</volume>(<issue>2</issue>):<fpage>249</fpage>-<lpage>54</lpage>; PMID:19144909; http://dx.doi.org/<pub-id pub-id-type="doi">10.1261/rna.1301109</pub-id><pub-id pub-id-type="pmid">19144909</pub-id></mixed-citation></ref><ref id="cit0084"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>CM</given-names></name>, <name><surname>Sehr</surname><given-names>P</given-names></name>, <name><surname>Putzker</surname><given-names>K</given-names></name>, <name><surname>Hentze</surname><given-names>MW</given-names></name>, <name><surname>Neumann</surname><given-names>B</given-names></name>, <name><surname>Duncan</surname><given-names>KE</given-names></name>, <name><surname>Thoma</surname><given-names>C</given-names></name></person-group>. <article-title>Automated high-throughput RNAi screening in human cells combined with reporter mRNA transfection to identify novel regulators of translation</article-title>. <source>PLoS One</source><year>2012</year>; <volume>7</volume>(<issue>9</issue>):<fpage>e45943</fpage>; PMID:23029333; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0045943</pub-id><pub-id pub-id-type="pmid">23029333</pub-id></mixed-citation></ref><ref id="cit0085"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>PS</given-names></name>, <name><surname>Jia</surname><given-names>J</given-names></name>, <name><surname>Yao</surname><given-names>P</given-names></name>, <name><surname>Majumder</surname><given-names>M</given-names></name>, <name><surname>Hatzoglou</surname><given-names>M</given-names></name>, <name><surname>Fox</surname><given-names>PL</given-names></name></person-group>. <article-title>A stress-responsive RNA switch regulates VEGFA expression</article-title>. <source>Nature</source><year>2009</year>; <volume>457</volume>(<issue>7231</issue>):<fpage>915</fpage>-<lpage>9</lpage>; PMID:19098893; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature07598</pub-id><pub-id pub-id-type="pmid">19098893</pub-id></mixed-citation></ref><ref id="cit0086"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essafi-Benkhadir</surname><given-names>K</given-names></name>, <name><surname>Onesto</surname><given-names>C</given-names></name>, <name><surname>Stebe</surname><given-names>E</given-names></name>, <name><surname>Moroni</surname><given-names>C</given-names></name>, <name><surname>Pages</surname><given-names>G</given-names></name></person-group>. <article-title>Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation</article-title>. <source>Mol Biol Cell</source><year>2007</year>; <volume>18</volume>(<issue>11</issue>):<fpage>4648</fpage>-<lpage>58</lpage>; PMID:17855506; http://dx.doi.org/<pub-id pub-id-type="doi">10.1091/mbc.E07-06-0570</pub-id><pub-id pub-id-type="pmid">17855506</pub-id></mixed-citation></ref><ref id="cit0087"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name>, <name><surname>Gu</surname><given-names>L</given-names></name>, <name><surname>He</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Zhou</surname><given-names>M</given-names></name></person-group>. <article-title>MDM2 regulates vascular endothelial growth factor mRNA stabilization in hypoxia</article-title>. <source>Mol Cell Biol</source><year>2011</year>; <volume>31</volume>(<issue>24</issue>):<fpage>4928</fpage>-<lpage>37</lpage>; PMID:21986500; http://dx.doi.org/<pub-id pub-id-type="doi">10.1128/MCB.06085-11</pub-id><pub-id pub-id-type="pmid">21986500</pub-id></mixed-citation></ref><ref id="cit0088"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vumbaca</surname><given-names>F</given-names></name>, <name><surname>Phoenix</surname><given-names>KN</given-names></name>, <name><surname>Rodriguez-Pinto</surname><given-names>D</given-names></name>, <name><surname>Han</surname><given-names>DK</given-names></name>, <name><surname>Claffey</surname><given-names>KP</given-names></name></person-group>. <article-title>Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis</article-title>. <source>Mol Cell Biol</source><year>2008</year>; <volume>28</volume>(<issue>2</issue>):<fpage>772</fpage>-<lpage>83</lpage>; PMID:18039850; http://dx.doi.org/<pub-id pub-id-type="doi">10.1128/MCB.02078-06</pub-id><pub-id pub-id-type="pmid">18039850</pub-id></mixed-citation></ref><ref id="cit0089"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joukov</surname><given-names>V</given-names></name>, <name><surname>Pajusola</surname><given-names>K</given-names></name>, <name><surname>Kaipainen</surname><given-names>A</given-names></name>, <name><surname>Chilov</surname><given-names>D</given-names></name>, <name><surname>Lahtinen</surname><given-names>I</given-names></name>, <name><surname>Kukk</surname><given-names>E</given-names></name>, <name><surname>Saksela</surname><given-names>O</given-names></name>, <name><surname>Kalkkinen</surname><given-names>N</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name></person-group>. <article-title>A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases</article-title>. <source>Embo J</source><year>1996</year>; <volume>15</volume>(<issue>7</issue>):<fpage>1751</fpage>; PMID:8612600<pub-id pub-id-type="pmid">8612600</pub-id></mixed-citation></ref><ref id="cit0090"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpanen</surname><given-names>T</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name></person-group>. <article-title>Molecular biology and pathology of lymphangiogenesis</article-title>. <source>Annu Rev Pathol</source><year>2008</year>; <volume>3</volume>:<fpage>367</fpage>-<lpage>97</lpage>; PMID:18039141; http://dx.doi.org/<pub-id pub-id-type="doi">10.1146/annurev.pathmechdis.3.121806.151515</pub-id><pub-id pub-id-type="pmid">18039141</pub-id></mixed-citation></ref><ref id="cit0091"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammela</surname><given-names>T</given-names></name>, <name><surname>Saaristo</surname><given-names>A</given-names></name>, <name><surname>Lohela</surname><given-names>M</given-names></name>, <name><surname>Morisada</surname><given-names>T</given-names></name>, <name><surname>Tornberg</surname><given-names>J</given-names></name>, <name><surname>Norrmén</surname><given-names>C</given-names></name>, <name><surname>Oike</surname><given-names>Y</given-names></name>, <name><surname>Pajusola</surname><given-names>K</given-names></name>, <name><surname>Thurston</surname><given-names>G</given-names></name>, <name><surname>Suda</surname><given-names>T</given-names></name>, et al.</person-group><article-title>Angiopoietin-1 promotes lymphatic sprouting and hyperplasia</article-title>. <source>Blood</source><year>2005</year>; <volume>105</volume>(<issue>12</issue>):<fpage>4642</fpage>-<lpage>8</lpage>; PMID:15746084; http://dx.doi.org/<pub-id pub-id-type="doi">10.1182/blood-2004-08-3327</pub-id><pub-id pub-id-type="pmid">15746084</pub-id></mixed-citation></ref><ref id="cit0092"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkkainen</surname><given-names>MJ</given-names></name>, <name><surname>Haiko</surname><given-names>P</given-names></name>, <name><surname>Sainio</surname><given-names>K</given-names></name>, <name><surname>Partanen</surname><given-names>J</given-names></name>, <name><surname>Taipale</surname><given-names>J</given-names></name>, <name><surname>Petrova</surname><given-names>TV</given-names></name>, <name><surname>Jeltsch</surname><given-names>M</given-names></name>, <name><surname>Jackson</surname><given-names>DG</given-names></name>, <name><surname>Talikka</surname><given-names>M</given-names></name>, <name><surname>Rauvala</surname><given-names>H</given-names></name>, et al.</person-group><article-title>Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins</article-title>. <source>Nat Immunol</source><year>2004</year>; <volume>5</volume>(<issue>1</issue>):<fpage>74</fpage>-<lpage>80</lpage>; PMID:14634646; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ni1013</pub-id><pub-id pub-id-type="pmid">14634646</pub-id></mixed-citation></ref><ref id="cit0093"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>X</given-names></name>, <name><surname>Yang</surname><given-names>D</given-names></name>, <name><surname>Hu</surname><given-names>J</given-names></name>, <name><surname>Hao</surname><given-names>X</given-names></name>, <name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Mao</surname><given-names>Z</given-names></name></person-group>. <article-title>Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma</article-title>. <source>Anticancer Res</source><year>2008</year>; <volume>28</volume>(<issue>3A</issue>):<fpage>1659</fpage>-<lpage>66</lpage>; PMID:18630523<pub-id pub-id-type="pmid">18630523</pub-id></mixed-citation></ref><ref id="cit0094"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoppmann</surname><given-names>SF</given-names></name>, <name><surname>Fenzl</surname><given-names>A</given-names></name>, <name><surname>Nagy</surname><given-names>K</given-names></name>, <name><surname>Unger</surname><given-names>S</given-names></name>, <name><surname>Bayer</surname><given-names>G</given-names></name>, <name><surname>Geleff</surname><given-names>S</given-names></name>, <name><surname>Gnant</surname><given-names>M</given-names></name>, <name><surname>Horvat</surname><given-names>R</given-names></name>, <name><surname>Jakesz</surname><given-names>R</given-names></name>, <name><surname>Birner</surname><given-names>P</given-names></name></person-group>. <article-title>VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival</article-title>. <source>Surgery</source><year>2006</year>; <volume>139</volume>(<issue>6</issue>):<fpage>839</fpage>-<lpage>46</lpage>; PMID:16782443; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.surg.2005.12.008</pub-id><pub-id pub-id-type="pmid">16782443</pub-id></mixed-citation></ref><ref id="cit0095"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>K</given-names></name>, <name><surname>Xiong</surname><given-names>J</given-names></name>, <name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Wu</surname><given-names>H</given-names></name>, <name><surname>Wang</surname><given-names>C</given-names></name></person-group>. <article-title>Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer</article-title>. <source>J Huazhong Univ Sci Technolog Med Sci</source><year>2006</year>; <volume>26</volume>(<issue>5</issue>):<fpage>562</fpage>-<lpage>4</lpage>; PMID:17219968; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/s11596-006-0520-9</pub-id><pub-id pub-id-type="pmid">17219968</pub-id></mixed-citation></ref><ref id="cit0096"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilov</surname><given-names>D</given-names></name>, <name><surname>Kukk</surname><given-names>E</given-names></name>, <name><surname>Taira</surname><given-names>S</given-names></name>, <name><surname>Jeltsch</surname><given-names>M</given-names></name>, <name><surname>Kaukonen</surname><given-names>J</given-names></name>, <name><surname>Palotie</surname><given-names>A</given-names></name>, <name><surname>Joukov</surname><given-names>V</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name></person-group>. <article-title>Genomic organization of human and mouse genes for vascular endothelial growth factor C</article-title>. <source>J Biol Chem</source><year>1997</year>; <volume>272</volume>(<issue>40</issue>):<fpage>25176</fpage>-<lpage>83</lpage>; PMID:9312130; http://dx.doi.org/<pub-id pub-id-type="doi">10.1074/jbc.272.40.25176</pub-id><pub-id pub-id-type="pmid">9312130</pub-id></mixed-citation></ref><ref id="cit0097"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacker</surname><given-names>SA</given-names></name>, <name><surname>Achen</surname><given-names>MG</given-names></name></person-group>. <article-title>From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy</article-title>. <source>Lymphat Res Biol</source><year>2008</year>; <volume>6</volume>(<issue>3-4</issue>):<fpage>165</fpage>-<lpage>72</lpage>; PMID:19093789; http://dx.doi.org/<pub-id pub-id-type="doi">10.1089/lrb.2008.1015</pub-id><pub-id pub-id-type="pmid">19093789</pub-id></mixed-citation></ref><ref id="cit0098"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnezis</surname><given-names>T</given-names></name>, <name><surname>Shayan</surname><given-names>R</given-names></name>, <name><surname>Caesar</surname><given-names>C</given-names></name>, <name><surname>Roufail</surname><given-names>S</given-names></name>, <name><surname>Harris</surname><given-names>NC</given-names></name>, <name><surname>Ardipradja</surname><given-names>K</given-names></name>, <name><surname>Zhang</surname><given-names>YF</given-names></name>, <name><surname>Williams</surname><given-names>SP</given-names></name>, <name><surname>Farnsworth</surname><given-names>RH</given-names></name>, <name><surname>Chai</surname><given-names>MG</given-names></name>, et al.</person-group><article-title>VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium</article-title>. <source>Cancer Cell</source><year>2012</year>; <volume>21</volume>(<issue>2</issue>):<fpage>181</fpage>-<lpage>95</lpage>; PMID:22340592; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.ccr.2011.12.026</pub-id><pub-id pub-id-type="pmid">22340592</pub-id></mixed-citation></ref><ref id="cit0099"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnezis</surname><given-names>T</given-names></name>, <name><surname>Shayan</surname><given-names>R</given-names></name>, <name><surname>Fox</surname><given-names>S</given-names></name>, <name><surname>Achen</surname><given-names>MG</given-names></name>, <name><surname>Stacker</surname><given-names>SA</given-names></name></person-group>. <article-title>The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway</article-title>. <source>Oncotarget</source><year>2012</year>; <volume>3</volume>(<issue>8</issue>):<fpage>893</fpage>-<lpage>906</lpage>; PMID:23097685<pub-id pub-id-type="pmid">23097685</pub-id></mixed-citation></ref><ref id="cit0100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacker</surname><given-names>SA</given-names></name>, <name><surname>Williams</surname><given-names>SP</given-names></name>, <name><surname>Karnezis</surname><given-names>T</given-names></name>, <name><surname>Shayan</surname><given-names>R</given-names></name>, <name><surname>Fox</surname><given-names>SB</given-names></name>, <name><surname>Achen</surname><given-names>MG</given-names></name></person-group>. <article-title>Lymphangiogenesis and lymphatic vessel remodelling in cancer</article-title>. <source>Nat Rev Cancer</source><year>2014</year>; <volume>14</volume>(<issue>3</issue>):<fpage>159</fpage>-<lpage>72</lpage>; PMID:24561443; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nrc3677</pub-id><pub-id pub-id-type="pmid">24561443</pub-id></mixed-citation></ref><ref id="cit0101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>K</given-names></name>, <name><surname>Osaki</surname><given-names>M</given-names></name>, <name><surname>Araki</surname><given-names>K</given-names></name>, <name><surname>Ishiguro</surname><given-names>K</given-names></name>, <name><surname>Ito</surname><given-names>H</given-names></name>, <name><surname>Ohgi</surname><given-names>S</given-names></name></person-group>. <article-title>Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas</article-title>. <source>Anticancer Res</source><year>2005</year>; <volume>25</volume>(<issue>4</issue>):<fpage>3003</fpage>-<lpage>9</lpage>; PMID:16080559<pub-id pub-id-type="pmid">16080559</pub-id></mixed-citation></ref><ref id="cit0102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzao</surname><given-names>C</given-names></name>, <name><surname>Lee</surname><given-names>SC</given-names></name>, <name><surname>Tung</surname><given-names>HJ</given-names></name>, <name><surname>Hsu</surname><given-names>HS</given-names></name>, <name><surname>Hsu</surname><given-names>WH</given-names></name>, <name><surname>Sun</surname><given-names>GH</given-names></name>, <name><surname>Yu</surname><given-names>CP</given-names></name>, <name><surname>Jin</surname><given-names>JS</given-names></name>, <name><surname>Cheng</surname><given-names>YL</given-names></name></person-group>. <article-title>Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma</article-title>. <source>Dis Markers</source>. <year>2008</year>; <volume>25</volume>(<issue>3</issue>):<fpage>141</fpage>-<lpage>8</lpage>; PMID:19096126; http://dx.doi.org/<pub-id pub-id-type="doi">10.1155/2008/468323</pub-id><pub-id pub-id-type="pmid">19096126</pub-id></mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000896 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000896 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:4905355
|texte= Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:27308508" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |